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Abstract 
Ticks act as vectors for a number of different pathogens such as Borrelia burgdorferi the 
causative agent of Lyme disease. The most prominent tick vector in the United States is 
the deer tick Ixodes scapularis. Tick bites are of special public health concern since there 
are no vaccines available against most tick transmitted pathogens. Based on the 
observation that host animals such as guinea pigs or humans can develop adaptive 
immune responses to tick bites, anti-tick vaccination is a potential approach to mitigate 
health risks associated with tick bites. 
The study presented here aimed at identifying immunogenic salivary proteins from 
I. scapularis recognized by human immune sera. To identify these potential antigens, 
which later on need to be characterized with regards to their vaccination potential, a phage 
display approach was utilized. Antigen libraries derived from salivary gland mRNA of 18 h 
fed I. scapularis were screened with human immune sera. 
Screening with an antigen library derived from nymphal ticks led to identification of a 
metalloprotease. This enzyme has been described previously and appears promising as a 
novel vaccine candidate. Furthermore, it has close homologs in other ixodid species 
raising its potential as a universal vaccine. 
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1 Introduction 
1.1 Ticks act as vectors for a number of disease causing agents 
 
Pathogen transmission by ticks is a worldwide problem that causes significant health risks 
and economic losses (Wikel and Alarcon-Chaidez, 2001). The hard tick Ixodes scapularis, 
which is prevalent in the United States especially in the north east, functions as a vector 
for a number of pathogens such as the Lyme disease spirochete Borrelia burgdorferi, as 
well as the agents of human anaplasmosis (Anaplasma phagocytophilum) (Dai et al., 
2010), human babesiosis (Babesia microti) and selected flaviviruses (Schuijt et al., 2011b) 
such as an encephalitits causing virus (Turtle et al., 2012) amongst other examples. There 
are currently no vaccines available for most of these tick-transmitted infections frustrating 
prevention of health risks posed by tick-bites. 
Ticks are obligate ectoparasites that require blood meals which can be taken from a vast 
array of different hosts such as mammals, birds or even reptiles (Francischetti et al., 
2009). Furthermore, the blood meal is essential for the tick with respect to life cycle 
progression. Ticks traverse through three different life cycle stages starting as larvae that 
hatch from eggs. After acquisition of their first blood meal, most commonly on small rodent 
hosts, the larvae overwinter and finally molt into nymphs. Nymphs require another blood 
meal before molting into adults (Brunner et al., 2011). Adult female Ixodes scapularis ticks 
take one last blood meal which is essential before oviposition and eventually die after the 
eggs have been laid (Francischetti et al., 2009). 
Interestingly, the rates of transovarian pathogen transmission from the adult tick to the 
eggs/larvae are very low, at least with regards to bacterial pathogens. Thus, larvae 
become infected when obtaining their first blood meal on a host that already carries the 
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pathogen (Brunner et al., 2011; Mather et al., 1989). Consequently, nymphal ticks receive 
a high significance when considering pathogen transmission to humans. 
Pathogen transmission can be classified as a bidirectional process in which tick feeding on 
a host is required, defining the tick as a vector for the respective pathogen. Additionally, 
the phenomenon of infection among co-feeding ticks has been observed in which the 
pathogen transfers from the infected tick to a non-infected tick feeding in close proximity 
(Jones et al., 1989). Many different studies outline the central role tick saliva plays in 
efficient feeding as well as pathogen transmission, strengthening the interest in saliva in 
vector biology. Also, the way in which the pathogen is sustained and keeps spreading 
becomes obvious as it utilizes the tick as a carrier to get from one host to another. In the 
case of B. burgdorferi, transmission via ticks is the only known mechanism by which 
humans become infected (Tilly et al., 2008). 
 
1.2 Saliva plays a central role in successful tick feeding 
Saliva plays a central role in tick-feeding and has been shown to have anti-hemostatic and 
anti-inflammatory effects as well as immuno-modulatory properties which impair the host’s 
innate and adaptive immune system. Saliva constitutes a highly complex pharmacological 
cocktail which contains numerous bioactive lipids and proteins that also act in redundant 
ways (Brossard and Wikel, 2004; Carvalho et al., 2010). Brossard and Wikel (2004) 
provide a very detailed description of tick saliva compounds and their actions in tick 
feeding. Amongst other examples they describe IL-8 binding proteins that inhibit binding of 
IL-8 to its receptor, prostaglandins that shift the expression pattern of cytokines towards a 
Th2 response, inhibitors of T cell activation like Salp15 or immunoglobulin binding proteins 
that prevent effector functions. 
Strengthening the importance of tick saliva in tick-borne disease transmission, studies 
have shown that pathogen transmission using its natural vector is more efficient than 
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artificial injections with a needle and syringe underlining the fact that saliva actively 
benefits pathogen transmission (Frischknecht, 2007). Additionally, pathogen transmission 
from the host to the tick is promoted by tick salivary proteins like the glutathione 
peroxidase Salp25D. Knock-down experiments for this protein have shown a decreased 
transmission of B. burgdorferi from infected hosts to the tick vector (Narasimhan et al., 
2007b). Furthermore, immunization of mice with recombinant Salp25D impaired pathogen 
transmission from the tick to the host (Das et al., 2001). 
A recent study using yeast-surface display identified five immunogenic salivary proteins 
from fully engorged I. scapularis nymphs capable of immunizing rabbits when given as a 
cocktail (Schuijt et al., 2011b). Results obtained by the same group revealed the 
importance of another salivary protein, tick histamine-release factor (tHRF), during late 
phases of the feeding process. When the tHRF gene was silenced by RNA interference, 
tick blood feeding success was impaired significantly (Dai et al., 2010). Since histamine is 
a pro-inflammatory cytokine, the effect achieved by tHRF seems to be counterintuitive. 
However, this finding leads to another important property of the salivary proteins: gene 
expression in the salivary glands during feeding is highly dynamic and adapts to the tick’s 
current requirements (McNally et al., 2012; Narasimhan et al., 2007a). This also leads to 
the necessity of clearly defining feeding time-points in studies of the feeding process and 
salivary gland expression dynamics (Ribeiro et al., 2006; Valenzuela et al., 2002). The 
dynamics of gene expression in the salivary glands also are represented by the fact that 
the feeding process can be divided into a total of nine different phases including host 
seeking, several different feeding stages as well as detachment (Anderson and Magnarelli, 
2008). Of special interest are the early phases of feeding in which the tick has to establish 
its bite site. It has been stated that in the first 24 h of the feeding process (which can last 
up to one week) only minute amounts of blood are taken up by the tick and that little to no 
pathogen transmission occurs (Dai et al., 2010). 
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1.3 Acquired tick-bite immunity 
Given that there are more than 20,000 new infections just of B. burgdorferi solely in the 
United States every year (Marques, 2010), the threat that ticks pose to human and animal 
health becomes abundantly clear. Nevertheless, the tick faces an impressive array of host 
defense mechanisms which need to be overcome in order to successfully obtain a blood 
meal (Brossard and Wikel, 2004; Francischetti et al., 2009). In addition to innate 
mechanisms like hemostasis or inflammation (Francischetti et al., 2008) many hosts have 
been shown to acquire specific tick-bite immunity (Ribeiro, 1995). 
The first scientific report of acquired immunity against ticks in guinea pigs was published 
over 70 years ago (Trager, 1939). This report describes that upon repeated infestation with 
the dog tick, Dermacentor variabilis, guinea pigs developed inflammatory reactions leading 
to impaired tick feeding and increased tick mortality rates (Trager, 1939). Similar results 
using other tick species and hosts such as rabbits or bovines have confirmed those early 
findings (Kashino et al., 2005; Wikel, 1996; Willadsen and Jongejan, 1999). 
Acquired tick immunity can manifest itself in many different ways. Among the valid 
definitions listed in the literature are decreased numbers of ticks engorging on a host or 
decreased weight of the ticks, as well as prolonged feeding, premature drop-off, 
decreased oviposition or even death of the tick as well as hypersensitivity reactions of the 
host (Wikel, 1996; Willadsen and Jongejan, 1999). 
Studies in mice have revealed critical components of the innate and adaptive immune 
system with respect to acquired tick bite immunity. A study focusing on basophils and mast 
cells as well as different Ig receptors on their surface showed that these cell types as well 
as immunoglobulins of the IgG and the IgE class are essential for acquired tick immunity 
(Wada et al., 2010). 
Immunization studies using bovines have confirmed the importance of immunoglobulins of 
the IgG class (Kashino et al., 2005). IgE antibodies have also repeatedly been reported as 
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central players in tick-bite hypersensitivity, making them exciting probes for immunogenic 
salivary protein discovery (Brossard and Wikel, 2004; Matsuda et al., 1990). 
Furthermore, acquired tick immunity has also been related to impaired pathogen 
transmission (Nazario et al., 1998; Wikel et al., 1997) leading to a simple but genuine idea: 
Preventing successful tick feeding on a host may prevent pathogen transmission. 
 
1.4 Vaccination against ticks 
The finding that acquired tick-bite immunity also affects pathogen transmission led to the 
idea of anti-tick vaccination. To date, there is only one commercially available anti-tick 
vaccine which is used in cattle and based on the midgut protein Bm86 from the cattle tick 
Boophilus microplus (de la Fuente et al., 2007a; de la Fuente et al., 2007b). For humans, 
there are currently no vaccines available against most of the pathogens transmitted by 
ticks. An efficient vaccine against tick vectors, however, would not only lower the 
vaccination burden for patients but also protect against a larger array of tick-borne 
diseases. Furthermore, it could provide an opportunity to decrease the application of 
acaricides which will have beneficial effects on the environment and agriculture. Also 
compromising the use of acaricides is the fact that some species of ticks have been 
observed to quickly develop resistance (Willadsen, 2004). The quest to identify 
immunogenic antigens that reveal a high efficacy in vaccination has proven difficult. 
Willadsen (2004) listed three different approaches that have been utilized to identify such 
potential antigens. First, he names the use of blood sera from tick immune animals as 
probes. A second approach is presented by analyses of proteins that are essential to the 
tick’s function and third, biochemical fractionation can be used to determine the minimal 
protein mixture that elicits a protective response when given as a vaccine (Willadsen, 
2004). 
 6 
 
Salivary proteins appear to be of special interest when it comes to identifying vaccine 
candidates and there are a number of different reports that have successfully identified 
immunogenic salivary proteins (Das et al., 2001; Schuijt et al., 2011a; Schuijt et al., 
2011b). It has been suggested that targeting salivary proteins of the early feeding phase (< 
24 h), in which it is also known that almost no pathogen transfer occurs, is sufficient to 
establish a sound immune response (Narasimhan et al., 2007a). However, limiting the 
search of novel vaccine candidates to salivary glands might appear somewhat 
shortsighted, since as it was stated above, the only commercially available vaccine is 
based on a midgut protein, revealing the importance of such concealed antigens (Nuttall et 
al., 2006). Host antibodies appear capable of traversing the host-tick interface where they 
can bind their respective antigens, for example in the tick’s gut, leading to damage of the 
tick after it has engorged on blood (Willadsen, 2004). Salivary protein antigens represent 
an excellent potential target for disrupting tick feeding and in particular, the pathogen 
transmission and infection process should pathogens reach host tissue. 
Besides immunogenicity, cross-species reactivity would be another desirable trait for an 
identified vaccine candidate. With more than 900 different tick species identified to date, a 
vaccine that protects against multiple species would be highly advantageous. In 
accordance with this notion it can be stated that there are a significant number of 
homologous proteins described between different species, a finding that confirms hopes 
for effective cross-species vaccines (Parizi et al., 2012). 
Finally, it has to be noted that tick-host interactions are typically specific, and that findings 
in one tick/host system cannot be extended to others without appropriate experimentation 
(Lawrie and Nuttall, 2001; Willadsen and Jongejan, 1999). This statement illustrates the 
highly complex interactions and reactions to different stimuli and also further complicates 
the identification of vaccine candidates, especially if laboratory animals are used to identify 
vaccines for future use in humans. 
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1.5 Phage Display 
Phage display is a robust technique suited for high-throughput screenings of specific and 
high-affinity interactions between biomolecules, especially proteins and peptides such as 
antibody fragments and/or antigens (Schirrmann et al., 2011). The technique was 
developed in the mid 1980s by George P. Smith (Smith, 1985). Since then, many 
improvements and modifications have been introduced such that phage display has 
become one of the most important affinity screening methods. 
The major strength of the system is established by the intrinsic connection of genotype 
and phenotype. This connection becomes clear after briefly considering the biology of 
filamentous phage which are primarily used for displaying proteins (Sidhu, 2005). 
Filamentous phage can be grouped into different strains such as M13, fd or f1. They are 
comprised of an outer protein capsid consisting primarily of the major coat protein pVIII 
which is responsible for up to 87% of the phages’ mass (Smith and Petrenko, 1997). The 
tips of the 1 µm long, rod shaped phage are built up by the minor coat proteins pIII and pXI 
on one end and pVII and pIX on the other end. Inside the phage particle, the ssDNA 
encoding all phage proteins is located. Filamentous phage infect their host E. coli via the F 
pilus present on the surface of the bacterial cell. pIII is essential for infection as its N-
terminus initiates the contact to the F pilus, eventually translocating the viral ssDNA into 
the cytoplasm. Here, the complementary DNA strand is synthesized by host enzymes to 
yield the replicative form, from which phage proteins are expressed. Finally, new phage 
particles are assembled and leave the host cell via a non-lytic mechanism (Barbas, 2001). 
Phage particles can now be utilized to display foreign proteins on their surface by fusion of 
the respective gene to the gene encoding one of the surface proteins, preferably pIII 
(Georgieva and Konthur, 2011). The result is a peptide::pIII fusion protein whose genetic 
information is directly encoded by the DNA located inside the phage particle. Thus, the 
connection of genotype and phenotype is achieved (Hust et al., 2006). The feature of 
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foreign peptides such as antibody fragments or potential antigens displayed on the phage 
surface permits efficient screening for interactions of these peptides with other molecules 
of interest. Such a screening is called biopanning (Konthur and Crameri, 2003). 
There are different strategies available for fusion of the gene of interest with the gene 
encoding the coat protein. Fusion directly within the phage genome is one opportunity, or 
use of specialized plasmids, called phagemids, which carry the respective coat protein 
gene and regulatory elements, can be utilized (Qi et al., 2012). 
Phage Display has been shown previously to be highly efficient with respect to screening 
large libraries containing antibody fragments and identifying binders to many different 
antigens (Colwill and Graslund, 2011; Hust et al., 2011). Conversely, the same 
methodology can be used to construct antigen libraries to identify potentially immunogenic 
proteins from various organisms (Kugler et al., 2008; Meyer et al., 2012; Naseem et al., 
2010). One major disadvantage of cDNA or gDNA expression libraries are non-functional 
inserts that are cloned in the wrong orientation, are not in frame with the gIII gene or 
leader peptide, or contain stop codons or parts of the untranslated regions (Georgieva and 
Konthur, 2011). 
An elegant way to tackle this issue is the introduction of a phagemid/helperphage system 
in which the helperphage (called Hyperphage) lacks a functional gIII (Rondot et al., 2001). 
In this case, the only functional pIII, which is essential for phage packaging, results from 
the phagemid and thus requires in-frame cloning of an insert that does not contain a stop 
codon. In the process of phage packaging these constructs are directly selected, leading 
to an enrichment of open reading frames (ORFs). Accordingly, the pHORF/Hyperphage 
system that has been published previously (Hust et al., 2006; Kugler et al., 2008; Meyer et 
al., 2012) was utilized in the study presented here. Figure 1-1 illustrates the whole process 
of library construction, packaging including ORF enrichment, biopanning and subsequent 
screening for immunogenic peptides. 
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Figure 1-1: Illustration of the construction of an antigen phage display library with subsequent packaging and 
ORF enrichment (top panel). After packaging of the library into phage particles a biopanning is performed 
using immobilized capture antibody and immune sera to enrich phage particles displaying immunogenic 
peptides. After three rounds of affinity enrichment a screening ELISA is performed to identify those phages 
displaying immunogenic peptides. Adapted from Meyer et al., 2012 
  
 10 
 
1.6 Goal of the study 
The goal of this master thesis research was to identify immunogenic proteins from the 
salivary glands of the deer tick, Ixodes scapularis. The criterion applied to classify a 
protein as immunogenic was its recognition by antibodies from human blood sera. Human 
subjects contributing blood sera were previously known to have strong immune responses 
to tick bites. 
To identify these salivary proteins, a phage display approach based on an antigen library 
constructed from mRNA of ticks, fed for 18 hours on a rodent host, was used. This antigen 
library was packaged into phage particles and screened against the human sera available 
as illustrated in Figure 1-1. 
Proteins selected in this analysis are predicted to function as novel vaccine candidates 
with special emphasis to application in humans. 
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2 Materials and Methods 
2.1 Equipment 
For the research carried out in this study the following equipment and devices were used. 
Table 2-1: Equipment used in this study 
Apparatus Model Manufacturer 
Blotting Machine Trans-Blot Turbo Bio-Rad, Munich 
Centrifuges 5415 D Eppendorf, Hamburg 
 5819 R Eppendorf, Hamburg 
 Sorval RC6 Plus Kendro, Langenselbold 
 Multifuge 3 S-R Heraeus, Hanau 
Cleanbenches Hera safe Heraeus, Hanau 
 MSCAdvantage Thermo Fisher Scientific, 
Bonn 
   
Electrophoresis chamber Biotechnology Model 40-
0708 
Peqlab, Erlangen 
 Mini Protean III for SDS 
PAGE 
Bio-Rad, Munich 
ELISA Reader Sunrise Tecan, Crailsheim 
ELISA Washer Columbus Pro Tecan, Crailsheim 
Gel Documentation Get Jet Imager Intas, Göttingen 
Incubators BE 400 Memmert, Schwabach 
 Certomat BS-1 B. Braun Biotech, 
Melsungen 
 Infors HT (shaking 
incubator) 
Infors, Einsbach 
 I-series 24 New Brunswick Scientific, 
Enfield, CT 
 6251 Thermo Scientific, Asheville, 
NC 
Pipettes Research Eppendorf, Hamburg 
Power Supplies Electrophoresis Power 
Supply 301 
Amersham Bioscience, 
Freiburg 
 Electrophoresis Power 
Supply 601 
 
Rocker GFL 3013 Omnilab Laborzentrum, 
Bremen 
Rotating Shaker Rotator RS-24 Kisker Biotech, Steinfurt 
Scales Analytic 1205MP Sartorius, Göttingen 
 Fine scale laboratory  
Thermocycler S1000 Thermal Cycler Bio-Rad, München 
 Mastercycler 621 Eppendorf, Hauppauge, NY, 
USA 
Thermomixer Compact Eppendorf, Hamburg 
 Comfort Eppendorf, Hamburg 
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Tissue Lyser Tissue Lyser II Qiagen, Valencia, CA, USA 
   
Ultrasound Sonicator Sonoplus Bandelin 
 Sonicator 3000 Misonix, Farmingdale, NY, 
USA 
Vortex REAX2000 Heidolph, Schwabach 
Water Installation Arium 611 Sartorius, Göttingen 
 
2.2 Consumable Supplies 
Consumable supplies utilized in this study are listed in the following table. 
Table 2-2: Consumable supplies used in this study 
Material Manufacturer 
Dynabeads M270 Carboxylic Acid Invitrogen Dynal AS, Oslo, Norway 
Disposable Cuvettes Brand, Wertheim 
Electroporation cuvettes 1 mm Bio-Rad, Munich 
Inoculation loops VWR, Darmstadt 
MTP 96 Well Flat Bottom Sarstedt, Nümbrecht 
MTP 96 Well Polypropylene, U-shaped Greiner-Bio-one, Frickenhausen 
MTP 96 Well Polystyrole, High Binding Costar, USA 
MTP cover foil AeraSeal Excel Scientific, Victorville, CA, USA 
MTP cover foil Sealplate  
PCR stripes Greiner-Bio-one, Frickenhausen 
Petri dishes (7 cm, 15 cm) Greiner-Bio-one, Frickenhausen 
Petri dishes, squared (24.5 cm) Sigma, Munich 
Pipette tips Sarstedt, Nümbrecht 
Pipette tips, filtered Greiner-Bio-one, Frickenhausen 
PVDF membrane Carl Roth, Karlsruhe 
Reaction tube (1.5 ml, 2 ml) Sarstedt, Nümbrecht 
Reaction tube (15 ml, 50 ml) Greiner-Bio-one, Frickenhausen 
Screw-top micro caps Sarstedt, Nümbrecht 
Spatulas VWR, Darmstadt 
Sterile filter (0.2 µm, 0.45 µm) Sartorius, Göttingen 
 
2.3 Kits and Markers 
The following kits were used for isolation and purification of nucleic acids. 
Table 2-3: Kits used in this study 
Kit Manufacturer 
Illustra mRNA purification Kit GE Healthcare, Piscataway, NJ, USA 
NucleoSpin Gel and PCR Clean-up Macherey-Nagel, Düren 
peqGOLD MINIprep Kit I Peqlab, Erlangen 
PlusOne Silver Staining Kit protein GE Healthcare, Piscataway, NJ, USA 
RNeasy MiniElute Clean-up Kit Qiagen, Valencia, CA, USA 
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Markers used in gel electrophoretic analyses (DNA and protein) are listed in the following 
table. 
Table 2-4: DNA and protein markers used in this study 
DNA Marker  
GeneRuler 1 kb Plus Ladder Fermentas, St. Leon-Rot 
100 bp DNA ladder NEB, Frankfurt a. M. 
Protein Marker  
Precision Plus Protein dual color Bio-Rad, Munich 
Precision Plus Protein unstained Bio-Rad, Munich 
 
2.4 Chemicals 
Unless noted differently, all chemicals were obtained from the following companies: 
Sigma-Aldrich Chemie GmbH, Fermentas GmbH, Merck KGaA, Riedel-de Haen-
Honeywell Specialty Chemicals Seelze GmbH, Roche Diagnostics GmbH, Carl Roth 
GmbH & Co.KG. Media supplements were obtained from Difco-Voigt Global Distribution 
Inc.  
For all solutions, media and buffers prepared, cleaned and completely desalted water was 
used (Arium 611, Sartorius AG). 
 
2.5 Enzymes 
Enzymes used in this study are listed in the following table. 
Table 2-5: Enzymes used in this study 
Enzyme Manufacturer 
AfeI NEB, Frankfurt a. M. 
Alkaline Phosphatase (CIP) NEB, Frankfurt a. M. 
AluI NEB, Frankfurt a. M. 
CviKI-1 NEB, Frankfurt a. M. 
E. coli DNA Ligase NEB, Frankfurt a. M. 
E. coli DNA Polymerase I NEB, Frankfurt a. M. 
ExTaq DNA Polymerase Takara 
GoTaq DNA Polymerase Sigma, Munich 
Large Klenow Fragment NEB, Frankfurt a. M. 
MMLV Reverse Transcriptase NEB, Frankfurt a. M. 
PmeI NEB, Frankfurt a. M. 
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RNAse H Invitrogen 
Superscript II Reverse Transcriptase Invitrogen 
T4 DNA Polymerase NEB, Frankfurt a. M. 
T4 Ligase Promega 
Trypsin Sigma, Munich 
 
2.6 Antibodies 
Antibodies used in this study are listed in the following table. Dilutions were always 
prepared in 2% MPBST unless noted otherwise. 
Table 2-6: Antibodies used in this study 
Antibody Dilution Manufacturer 
Mouse α-M13 IgG (fd, F1), 
monoclonal 
1:1000 
Progen, Heidelberg 
Mouse α-human IgG (Fc specific), 
monoclonal 1:5000 
Sigma, Munich 
Goat α-human IgG (Fc specific)-
Peroxidase conjugated, polyclonal 1:70000 
Sigma, Munich 
Mouse α-M13-Peroxidase 
conjugated, monoclonal 1:40000 
GE Healthcare 
Goat α-human IgG polyvalent 1:6700 Sigma, Munich 
Goat α-human IgG (Fc specific) 
phosphatase conjugated 
1:5000 
Dianova, Hamburg 
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2.7 Bacteria, Bacteriophages and Plasmids 
Bacterial strains as well as bacteriophages used in this study are listed in the following 
table. 
Table 2-7: Bacteria and helperphages used in this study 
Bacterial Strain Genotype Source 
E. coli XL1-Blue-MRF’ K12: Δ(mcrA)183 Δ(mcrCB-
hsdSMR-mrr)173 endA1 
supE44 thi-1 recA1 gyrA96 
relA1 lac [F‘ proAB lacIqZ 
ΔM15 Tn10 (TetR)  
 
Stratagene 
E. coli Top10F’ K12: F- mcrA Δ(mrr-
hsdRMS-mcrBC) 
φ80lacZΔM15 ΔlacX74 
nupG recA1 araD139 Δ(ara-
leu)7697 galE15 galK16 
rpsL(StrR) endA1 λ-  
 
Invitrogen 
E. coli DH5α 409-1 (K02)  Rondot et al., 2001 
Helperphage Hyperphage  AG Dübel, TU 
Braunschweig 
 
 
Plasmids used in this study are listed in the following table. 
Table 2-8: Plasmids used in this study 
Plasmid Description Source 
pHORF3 Phagemid vector, Cloning of 
antigen-libraries, Phage-
Display, PmeI restriction site 
AG Dübel, TU 
Braunschweig 
 
2.8 Ticks 
2.8.1 Housing 
Pathogen-free Ixodes scapularis nymphs were reared using standard methods (Mather 
and Mather, 1990). All unfed nymphs were generated from larvae derived from field-
collected adult females blood fed in the laboratory. Larvae were blood fed on pathogen-
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free hamsters, collected and allowed to molt under environmental conditions of 23°C, 
>90% relative humidity, and a 14 h light/10 h dark photoperiod. 
Adult female Ixodes scapularis used in this study were field collected and housed under 
environmental conditions of 23°C, >90% relative humidity, and a 14 h light/10 h dark 
photoperiod. 
2.8.2 Feeding 
In all feeding experiments performed in this study, ticks were allowed to feed on a rodent 
host (mouse or hamster) for 18 hours. After 18 hours ticks were pulled off the host and 
stored in a glass vial with a wet paper towel until subsequent dissection. All animal studies 
were performed in accordance with protocols AN04-10-006 and AN08-04-017 under the 
University of Rhode Island, Institutional Animal Care and Use Committee (IACUC). 
2.8.3 Dissections 
For dissections, fed ticks were immobilized on a glass slide previously prepared with 
double sided sticky tape. 15 µl of PBS were placed on the tick and the animal was opened 
using a razor blade. Salivary glands were dissected using fine needles and transferred 
either into ice cold PBS or mRNA Extraction buffer at room temperature depending on the 
experiment. 
2.8.4 Preparation of salivary gland homogenate (SGH) 
Salivary glands dissected previously and stored in PBS (see section 2.8.3) were placed on 
ice. Samples were sonicated three times for 20 s using the Sonicator 3000 at an intensity 
of 5.0. Between each sonication step the sample was centrifuged at 10,000 x g and 4°C 
for 2 min. After the third sonicaion step the samples were centrifuged for 10 min and all 
resulting supernatants were pooled. This pool was centrifuged again for 10 min at 10,000 x 
g and 4°C and the resulting supernatant was stored at -80°C. 
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2.9 Media 
2.9.1 Culture media for Escherichia coli 
Unless noted otherwise, E. coli were cultured in fully buffered two times yeast-tryptone 
media (2xYT). For solid media 15 g agar per liter were added. 
Table 2-9: Recipe for 2xYT medium 
2xYT Medium  
Bacto-Yeast Extract 1.0 % (w/v) 
Bact-Tryptone 1.6 % (w/v) 
NaCl 0.5 % (w/v) 
 
Table 2-10: Recipe for SOC medium 
SOC Medium  
Bacto-Yeast Extract 0.5 % (w/v) 
Bact-Tryptone 2.0 % (w/v) 
NaCl 0.05 % (w/v) 
Glucose 1.8 % (w/v) 
 
2.9.2 Media Supplements 
Media supplements were prepared as concentrated stock solutions and autoclaved or filter 
sterilized. Addition of supplements to the media was performed under sterile conditions. 
For solid media supplements were added after media had reached a temperature below 
55°C. 
Table 2-11: Media supplements used in this study 
Supplement Stock solution Final concentration 
Ampicillin 100 mg/ml 100 µg/ml 
Kanamycin 50 mg/ml 50 µg/ml 
Tetracycline 10 mg/ml 20 µg/ml 
Glucose 2 M 100 mM 
IPTG 1 M 0.5 mM 
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2.10 Buffers and Solutions 
For all solutions and buffers prepared, cleaned and completely desalted water was used 
(Arium 611, Sartorius AG). Concentrations listed are in water unless noted otherwise. 
Table 2-12:  Buffers and solution used in this study 
Acrylamide Mix 
Acrylamide 
Bisacrylamide 
 
30 
0.8 
 
% 
% 
 
(w/v) 
(w/v) 
 
Agarose Gel 
Agarose 
 
1.0 
 
% 
 
(w/v) 
 
in TAE Buffer 
Ammonium Peroxosulphate (APS-) Solution 
APS 
 
10 
 
% 
 
(w/v) 
 
Blotting Buffer 
Tris 
Glycine 
 
25 
192 
 
mM 
mM 
  
Carbonate Buffer 
NaHCO3, pH 9.6 
 
50 
 
mM 
  
ELISA Blocking Buffer 
Milk powder 
 
2 
 
% 
 
(w/v) 
 
in PBS 
ELISA Washing Buffer 
Tween20 
 
0.05 
 
% 
 
(w/v) 
 
in PBS 
Ethidium Bromide Solution 
Ethidium Bromide 
 
0.1 
 
% 
 
(w/v) 
 
Laemmli Buffer (5x) 
SDS 
Glycerol 
Bromophenol Blue 
β-Mercaptoethanol 
 
10 
50 
0.02 
15 
 
% 
% 
% 
% 
 
(w/v) 
(w/v) 
(w/v) 
(v/v) 
 
MPBS-T 
Milk Powder 
 
2 
 
% 
 
(w/v) 
 
in PBS-T 
PBS 
NaCl 
KCl 
Na2HPO4 x 2 H2O 
KH2HPO4 
 
0.8 
0.02 
0.144 
0.024 
 
% 
% 
% 
% 
 
(w/v) 
(w/v) 
(w/v) 
(w/v) 
 
PBS-T 
Tween20 
 
0.05 
 
% 
 
(v/v) 
 
in PBS 
PEG/NaCl 
PEG 6000 
NaCl 
 
20 
2.5 
 
% 
M 
 
(w/v) 
 
Phage Dilution Buffer 
Tris 
NaCl 
EDTA 
 
10 
20 
2 
 
mM 
mM 
mM 
  
Stacking Gel Buffer (for SDS Gel) 
Tris-HCl, pH 6.8 
 
1.0 
 
M 
  
SDS-PAGE Running Buffer 
Tris 
 
25 
 
mM 
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Glycine 
SDS 
192 
0.1 
mM 
% 
 
(w/v) 
SDS Solution 
SDS 
 
10 
 
% 
 
(w/v) 
 
TAE Buffer 
Tris-HCl 
Acetic acid 
EDTA 
 
4 
2 
1 
 
mM 
mM 
mM 
  
TMB Reagent 
Solution A, pH 4.1 
Potassium Citrate 
Citric acid 
Solution B 
Tetramethylbenzidine 
Acetone 
Ethanol 
Hydrogen peroxide 
 
 
30 
0.5 
 
10 
10 
90 
0.3 
 
 
mM 
M 
 
mM 
% 
% 
% 
 
 
 
 
 
 
(v/v) 
(v/v) 
(v/v) 
 
Separating Gel Buffer (for SDS Gel) 
Tris 
 
1.5 
 
M 
  
Western Blot Substrate Buffer 
Tris HCl 
MgCl2 
 
100 
0.5 
 
mM 
mM 
  
 
2.11 Oligonucleotides 
Primers used for PCR and reverse transcription experiments are listed in the following 
table. 
Table 2-13: Oligonucleotides used in this study 
Primer Name Sequence 5’ à 3’ 
MHLacZPro_f GGCTCGTATGTTGTGTGG  
MHgIII_r CTAAAGTTTTGTCGTCTTTCC  
Random Hexamers Obtained from Invitrogen 
3’ SMART CDS Primer II A AAGCAGTGGTATCAACGCAGAGTACT(30)AT 
SMART II A Oligonucleotide AAGCAGTGGTATCAACGCAGAGTACGCGGG 
5’ PCR Primer II A AAGCAGTGGTATCAACGCAGAGT 
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2.12 Software and Databases 
Software and Databases used in this study are listed in the following table. 
Table 2-14: Software used in this study 
Software Application 
ExPASy Prot Scale Online Tool to generate protein hydrophobicity plots 
http://web.expasy.org/protscale/ 
Geneious Vector Management, Sequence analysis, virtual cloning 
MultAlin Interface Online Sequence alignment tool 
http://multalin.toulouse.inra.fr/multalin/ 
NCBI Literature research, sequence comparisons (BLAST), 
gene and protein sequence information  
http://www.ncbi.nlm.nih.gov/  
 
2.13 Microbiological Methods 
2.13.1 Liquid and solid culture media 
All media were sterilized by autoclaving (121°C, 20 min, excess pressure 1 bar). Heat 
sensitive supplements were filter sterilized (pore size 0.2 µm) and added to the media 
under sterile conditions. For solid media Agar-Agar (Bacto) was added before autoclaving. 
2.13.2 Culture Techniques 
2.13.2.1 Plating 
After transformation or transduction of E. coli, cell suspension was plated on a 2xYT Agar 
plate supplemented with 0.1 M glucose and the respective antibiotic with a spatula. 
Incubation was performed at 37°C overnight. Plates were stored at 4°C for up to four 
weeks after sealing with Parafilm. 
2.13.2.2 Liquid cultures 
Starter cultures were prepared in 5 ml or 30 ml scale in 2xYT media supplemented with 
0.1 M glucose and the respective antibiotic. Inoculation was performed either from a single 
colony taken from a plate or directly from a glycerol stock. Cultures were incubated at 
37°C and 250 rpm for 16 to 18 hours in a shaking incubator. 
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Main cultures of volumes between 50 and 400 ml were inoculated from the starter culture 
with OD600 adjusted to 0.05 to 0.09. Composition of the medium was generally set up as 
for the starter culture. Incubation of the main culture was performed at 37°C and 250 rpm 
in a shaking incubator until OD600 of 0.5 was reached. 
2.13.3 Preparation and transformation of E. coli TOP10F’ electrocompetent cells 
2.13.3.1 Preparation 
1200 ml 2xYT medium were inoculated with 20 ml of an E. coli TOP10F’ starter culture to 
reach an OD600 = 0.06 and incubated at 37°C and 250 rpm until an OD600 of 0.5 was 
reached. Next, the culture was incubated on ice for 30 min followed by a centrifugation 
step at 4000 x g, 4°C for 15 min. The cell pellets were resuspended in 800 ml ice-cold 
dH2O followed by another centrifugation step at 4000 x g, 4°C for 20 min. This wash step 
was repeated once. Following, the cell pellets were resuspended in 200 ml ice-cold 10% 
glycerol and centrifuged at 3220 x g, 4°C for 10 min in 50 ml reaction tubes. Resuspension 
of the cell pellets was performed in 1.6 ml ice-cold 10% glycerol and aliquots of 200 µl 
were stored at -80°C until use. 
2.13.3.2 Transformation 
Prior to electroporation the electrocompetent E. coli TOP10F’ cells were thawed on ice. 
DNA derived from a ligation was added to 50 µl electrocompetent cells and incubated on 
ice for 5 min. Subsequently the DNA-cell suspension was filled into pre-chilled cuvettes 
and electroporation was performed with a pulse of 1.7kV. 1 ml SOC medium with a 
temperature of 37°C was added immediately and the cells were incubated at 37°C and 
600 rpm for 1 h. Finally the whole cell suspension was plated on 2xYT agar plates 
supplemented with 0.1 M glucose and the respective antibiotic. The plate was incubated 
over night at 37°C. 
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For construction of antigen libraries, the resulting colonies were floated off the agar with 
40 ml 2xYT medium. The resulting cell suspension was centrifuged at 3220 x g, 4°C for 15 
min. The pellet was resuspended in 2xYT medium containing 20% glycerol and the sample 
was stored at -80°C. 
2.13.4 Preparation of E. coli cell lysate 
A 40 ml starter culture was centrifuged at 3220 x g for 15 min and the pellet was 
resuspended in 40 ml PBS. The pellet was washed two more times with 40 ml PBS. Cell 
lysis was performed by the application of ultrasound to the sample with a power output of 
65% (Sonotrode MS73) for 5 cycles. The resulting suspension was stored at  
-20°C. 
2.13.5 Affinity-Selection of antigen-phage from libraries 
2.13.5.1 Production of the helperphage Hyperphage 
A starter culture of E. coli DH5α 409-1 (K02) was incubated over night at 37°C and 
250 rpm in 2xYT-GK medium. 400 ml 2xYT-GK were inoculated with 200 µl starter culture 
and induction of Hyperphage production was achieved by addition of 0.5 mM IPTG. The 
culture was incubated at 30°C and 250 rpm for 24 hours. Afterwards, the cell suspension 
was centrifuged at 6000 x g, 4°C for 20 min and the supernatant was transferred into a 
fresh tube. For precipitation of the phage 1/5 volume PEG/NaCl was added to the 
suspension which was subsequently incubated on ice at 4°C over night. The phage were 
then pelleted by centrifugation at 10,000 x g, 4°C for 1 h. The supernatant was discarded 
and the pellet was resuspended in 20 ml phage dilution buffer and filter sterilized (pore 
size 0.45 µm). Again 1/5 volume PEG/NaCl was added and the sample was incubated on 
ice for 1 h followed by a centrifugation at 20,000 x g, 4°C for 20 min. The resulting pellet 
was resuspended in 5 ml phage dilution buffer and the Hyperphage suspension was 
stored at 4°C and subject to titration. 
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2.13.5.2 Packaging of antigen-phage libraries 
400 ml 2xYT-GA medium were inoculated with 1 ml from a glycerol stock containing the 
respective library and the culture was grown at 37°C and 250 rpm until an OD600 of 0.5 
was reached. 25 ml from that culture were transferred to 50 ml reaction tubes and infected 
with 2.5 x 1011 CFU Hyperphage. Infection was achieved by incubating at 37°C for 30 min 
followed by a second incubation for 30 min at 37°C and 250 rpm. After centrifugation at 
3220 x g for 10 min the cell pellet was resuspended in 400 ml 2xYT-AK and the culture 
was incubated over night at 30°C and 250 rpm. Precipitation of the phage particles was 
performed as described above for the production of Hyperphage. The packaged library 
was stored at 4°C in 2 ml screw top vials and subject to titration. 
2.13.5.3 Determination of phage titers 
50 ml 2xYT-T medium were inoculated with 200 µl of an E. coli XL1 blue MRF’ or an  
E. coli TOP10F’ starter culture and the culture was grown at 37°C and 250 rpm until an 
OD600 of 0.5 was reached. To determine the phage titers after packaging of a library or of 
the eluted phage after a panning round, 10 µl of the phage sample diluted in phage dilution 
buffer were added to 50 µl E. coli culture and the samples were incubated at 37°C for 30 
min. Dilutions were prepared starting at 10-2 and continuing in steps of two orders of 
magnitude until a dilution of 10-10 was reached. After the 30 min incubation 10 µl of each 
dilution were plated in triplicate, air-dried and incubated at 37°C over night. Additionally, a 
positive control, as well as negative controls containing cells only, cells plus phage dilution 
buffer and phage only, were plated. 
2.13.5.4 Panning 
For the specific selection of immunogenic antigen-phage mouse α-human IgG (Fc specific) 
monoclonal antibody was diluted 1:5000 in carbonate buffer and 100 µl were immobilized 
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in the well of a MTP (Costar) at 4°C overnight. In parallel, human blood serum was pre-
incubated at 4°C overnight as outlined in the following table. 
Table 2-15: Composition of the serum pre-incubation mixture 
Component Concentration 
Patient serum 1:10 
Hyperphage 1 x 1011 phage/ml 
E. coli cell lysate 10% 
2% MPBST To adjust volume 
 
After coating overnight all wells of the MTP were emptied and blocked with 350 µl 
2% MPBST for 1.5 h at room temperature followed by three washing steps with PBST 
using an ELISA washer. Next, the pre-incubated patient serum was filled into the wells and 
incubated at room temperature for 2 h followed by three washing steps with PBST. After 
capturing the serum antibodies, 200 µl of the packaged antigen phage from the library or 
the previous panning round were filled into the wells and the MTPs were incubated for 2 h 
at room temperature. This incubation was followed by 10 x N stringent washing steps with 
PBST where N = number of the panning round. Specifically bound phage particles were 
eluted by addition of 200 µl Trypsin solution (10 µg/ml) to each well and incubation at 37°C 
for 30 min. 190 µl of the eluted phage were used to reinfect E. coli TOP10F’ and amplify 
the phage. The remaining 10 µl were used for titration of the eluted phage. In each 
selection experiment three rounds of panning were performed. 
2.13.5.5 Infection of E. coli and production of antigen-phage 
To amplify eluted phage 50 ml 2xYT-T medium were inoculated with 200 µl of an E. coli 
TOP10F’ starter culture and the culture was grown at 37°C and 250 rpm until an OD600 of 
0.5 was reached. To 20 ml of that culture the eluted phage were added and the mixture 
was incubated at 37°C for 30 min followed by a second incubation for 30 min at 37°C and 
250 rpm. Next, the re-infected cells were pelleted by centrifugation at 3220 x g for 10 min. 
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The pellet was resuspended in 250 µl 2xYT medium and plated on a 15 cm 2xYT-GA agar 
plate. The plate was incubated at 37°C overnight. 
Colonies were floated off the agar plate using 5 ml 2xYT medium. To 1 ml of the cell 
suspension 300 µl 80% glycerol were added and the sample was stored at -80°C. 
Approximately 250 µl of the cell suspension were used to inoculate 50 ml 2xYT-GA 
medium to an OD600 of 0.05 to 0.09. The culture was subsequently grown at 37°C and 250 
rpm until an OD600 of 0.5 was reached. 5 ml of this culture were infected with 5 x 10
11 
Hyperphage particles by incubation at 37°C for 30 min followed by a second incubation for 
30 min at 37°C and 250 rpm. The cells were pelleted at 3220 x g for 10 min and the pellet 
resuspended in 30 ml 2xYT-AK followed by an incubation at 30°C and 250 rpm overnight. 
To precipitate the phage particles, cells were pelleted at 3220 x g for 10 min and the 
supernatant was mixed with 1/5 volume PEG/NaCl and incubated on a rocker on ice for 1 
h. After centrifugation at 20,000 x g, 4°C for 1 h the pellet was resuspended in 10 ml 
phage dilution buffer and filter sterilized (pore size 0.45 µm). Again 1/5 volume PEG/NaCl 
was added and the suspension incubated on ice on a rocker for 1 h followed by a 
centrifugation step at 20,000 x g, 4°C for 1 h. The pellet containing the phage particles was 
resuspended in 500 µl phage dilution buffer and stored at 4°C until it was used in the next 
panning round. 10 µl were used to titer the amplified phage. 
2.13.5.6 Production of antigen-phage in microtiter plates 
The wells of a microtiter plate (96 well, flat bottom, Sarstedt) were filled with 150 µl 2xYT-
GA medium and each well was inoculated with a single colony resulting from the third 
panning round of an antigen-phage selection experiment. As negative control the wells H3 
and H6 were not inoculated (master plate). A previously validated positive control was not 
available. The plate was incubated overnight at 37°C and 300 rpm. A new microtiter plate 
(96 Well, flat bottom, Sarstedt) was filled with 150 µl 2xYT-GA medium and each well was 
inoculated with 10 µl from the respective well of the master plate and incubated for exactly 
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2 h at 37°C and 300 rpm. Next, 5 x 109 Hyperphage particles were added to each well and 
the plate was incubated at 37°C for 30 min followed by a second 30 min incubation at 
37°C and 300 rpm. Subsequently the bacteria were pelleted by centrifugation at 3220 x g 
for 10 min and the supernatant was discarded. The pellets were resuspended in 150 µl 
2xYT-AK and the plate was incubated at 37°C and 300 rpm overnight. 
Bacteria in the master plate were pelleted at 3220 x g for 10 min and the supernatant was 
discarded. The pellets were resuspended in 2xYT-GA medium containing 20% glycerol 
and the master plate was stored at -80°C. 
The production plate was centrifuged at 3220 x g for 10 min and the supernatants were 
transferred to a fresh microtiter plate (96 Well, flat bottom, Sarstedt). 40 µl PEG/NaCl were 
added to each well and the plate was incubated on ice at 4°C overnight. Phage particles 
were pelleted by centrifugation at 3220 x g for 1 h at 4°C. The supernatants were 
discarded and the phage pellets resuspended in 150 µl phage dilution buffer. The plate 
was centrifuged again at 3220 x g for 10 min to pellet remaining bacteria and supernatants 
were transferred to a fresh microtiter plate (96 Well Polypropylene, U-shaped, Greiner Bio-
one). 
 
2.14 Molecular Biological Methods 
2.14.1 Preparation of Plasmid DNA from E. coli 
Preparation of plasmid DNA was performed using the peqGOLD Miniprep Kit I (peqlab, 
Erlangen). E. coli carrying the plasmid of interest were cultured in 5 ml 2xYT-GA medium 
at 37°C and 250 rpm overnight. The cells were harvested by centrifugation at 5000 x g for 
10 min and plasmid DNA was isolated according to the supplier’s instructions. 
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2.14.2 DNA Amplification via Colony Polymerase Chain Reaction (CPCR) 
A colony PCR was performed after construction of the antigen libraries to obtain an 
overview of the distribution of different insert sizes of each library. The DNA template 
originated from a single bacterial colony which was picked with a sterile pipette tip and 
directly inoculated into the aliquoted PCR master mix. The polymerase used was GoTaq-
DNA-Polymerase. PCR approaches were 10 µl in volume containing one-fifth of the 5x 
GoTaq Buffer as well as 200 µM dATP, dCTP, dGTP and dTTP. The final concentration of 
each primer used was 500 nM and each approach contained 0.025 U GoTaq-DNA-
Polymerase. The PCR program is summarized in the following table. 
Table 2-16: PCR program used for colony PCR analysis 
Cycles Temperature (°C) Description Duration 
1 95 Melting of the DNA 120 s 
24 
94 Melting of the DNA 15 s 
56 Primer Annealing 20 s 
72 Elongation 90 s 
1 72 Final Elongation 300 s 
1 16 Storage ∞ 
 
2.14.3 Preparation of mRNA from tick salivary glands 
Preparation of mRNA was performed using the Illustra mRNA purification Kit (GE 
Healthcare). Adult or nymphal Ixodes scapularis were allowed to feed on a rabbit or rodent 
host for 18 h. Subsequently, the salivary glands were extracted as outlined in section 2.8.3 
and directly transferred into mRNA Extraction Buffer (GE Healthcare). The tissues were 
homogenized in two cycles of 2 min each at a frequency of 20 Hz using the Tissue Lyser II 
(Qiagen). Subsequently, the mRNA was isolated according to the supplier’s instructions. 
The mRNA obtained was further purified and concentrated using the RNeasy Mini Elute 
clean-up Kit (Qiagen) according to the supplier’s instructions. The mRNA was eluted in a 
total volume of 13 µl. 
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2.14.4 Conventional cDNA synthesis 
To synthesize the first strand cDNA, 13 µl salivary gland mRNA were mixed with 7.5 µg 
random hexamer primers and 1.25 µl dNTPs (10 mM). The volume was brought to 16.5 µl 
with nuclease free water and the sample was incubated at 70°C for 5 min followed by a 5 
min incubation on ice. Next, 5 µl First Strand Buffer (Invitrogen), 2.5 µl DTT (0.1 M) and 
1 µl Superscript II Reverse Transcriptase (Invitrogen) were added and the sample was 
incubated at 25°C for 10 min followed by 50 min at 42°C. After a final incubation for 15 min 
at 70°C the first strand cDNA was either stored at 4°C or directly used for second strand 
synthesis. 
To synthesize the second strand, the whole first strand sample containing the RNA-DNA 
hetero-duplex was mixed with 10 U E. coli DNA Ligase, 40 U E. coli DNA Polymerase I 
and 2 U RNase H. 15 µl 10x E. coli Ligase Buffer were added and the volume was 
adjusted to 150 µl with nuclease-free water. The sample was vortexed gently and 
incubated at 16°C for 2 h. After addition of 10 U T4 DNA Polymerase, the sample was 
incubated at 16°C for another 5 min followed by addition of 10 µl of 0.5 M EDTA. The 
double stranded cDNA was isolated from this mixture by adding 160 µl 
phenol:chloroform:isoamyl alcohol (25:24:1) and thorough shaking. After centrifuging for 5 
min at 14,000 x g, the upper aqueous layer was removed and the DNA precipitated by 
addition of 70 µl 3 M Sodium Acetate (pH 5.2) and 500 µl ice-cold ethanol. After 
centrifuging for 20 min at 14,000 x g, the supernatant was discarded and the pellet washed 
once with ice-cold 70% ethanol. Finally the pellet was resuspended in 14 µl nuclease-free 
water. 
2.14.5 SMART cDNA synthesis 
Tick salivary gland derived mRNA was used to generate double-stranded cDNA for 
subsequent cloning into pHORF3. To prepare first strand cDNA, 13 µl mRNA (at least 
25 ng) were mixed with 1 µl 3’ SMART CDS Primer II A (12 µM) and 1 µl SMART II A 
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Oligonucleotide. The mixture was incubated at 72°C for 2 min to abrogate secondary 
structures within the mRNA, followed by an incubation on ice for 2 min. After a brief 
centrifugation 4 µl 5x First Strand Buffer (Invitrogen), 0.2 µl DTT, 1 µl dNTP Mix (10 mM 
each) and 1 µl M-MLV reverse transcriptase (Invitrogen) were added and the mixture was 
incubated at 37°C for 1 h yielding first strand cDNA. For the synthesis of the second strand 
a long distance PCR was performed using the following master mix: 
Table 2-17:  Master Mix prepared for the long-distance PCR performed during SMART cDNA synthesis 
Component Volume 
10x ExTaq Buffer 5.00 µl 
dNTP Mix (2.5 mM each) 4.00 µl 
5’ PCR Primer II A (12 µM) 2.00 µl 
ExTaq DNA Polymerase 0.25 µl 
dH2O 36.75 µl 
Total Volume 48.00 µl 
 
Aliquots of 48 µl master mix were filled into PCR tubes and 2 µl of first strand cDNA were 
added. The PCR program for the synthesis of the second strand is summarized in the 
following table. 
Table 2-18: PCR program used for the long-distance PCR 
Cycles Temperature (°C) Description Duration 
1 95 Melting of the DNA-RNA Hybrid 60 s 
24 
95 Melting of the DNA 15 s 
65 Primer Annealing 30 s 
72 Elongation 6 min 
1 72 Final Elongation 10 min 
1 4 Storage ∞ 
 
2.14.6 Restriction Digest of DNA 
To eliminate untranslated regions from the full length transcripts obtained from the SMART 
cDNA synthesis and to generate blunt ended DNA fragments suitable for cloning into 
pHORF3, a restriction enzyme digest using the blunt end cutters AfeI, AluI and CviKI-1 
was performed. 30 µl SMART cDNA (~1.7 µg) were mixed with 1.25 U of each of the 
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restriction enzymes named above as well as NEBuffer 4 and BSA in a total volume of 
100 µl. The sample was incubated at 37°C for 10 min followed by a heat inactivation at 
65°C for 20 min. 
The phagemid vector pHORF3 was linearized by digestion with the blunt cutting enzyme 
PmeI. Incubation was performed at 37°C overnight followed by heat inactivation at 65°C 
for 10 min. To avoid religation, the vector was dephosphorylated with 0.5 µl alkaline 
phosphatase (calf intestinal phosphatase, CIP) at 37°C for 30 min. Linearized and 
dephosphorylated vector was cleaned up using the NucleoSpin Kit (Macherey Nagel) and 
stored at -20°C. 
2.14.7 DNA polishing 
To obtain blunt ended DNA fragments for cloning of cDNA from the conventional cDNA 
synthesis into pHORF3, the DNA needed to be polished. To achieve this, the cDNA was 
mixed with 1mM dNTPs, 15 U T4 DNA Polymerase and 5 µg BSA. Also 5 µl NEBuffer 2 
was added and the volume brought to 50 µl. The sample was incubated at 25°C for 10 min 
followed by the addition of 12.5 U Large Klenow Fragment and another incubation at 25°C 
for 10 min followed by a 2 h incubation at 16°C. The blunt-ended DNA was cleaned up 
using the NucleoSpin Kit (Macherey Nagel). 
2.14.8 Agarose Gel Electrophoresis 
In an agarose gel ectrophoresis, DNA fragments were separated in an electric field, 
proportional to the negative logarithm of their molecular mass. Thus, 1% (w/v) agarose 
gels were supplemented with 10 µl ethidium bromide solution per 35 ml of gel and the 
separation was performed at a constant voltage of 120 V for 30 min in TAE buffer. 
Documentation of the DNA fragments was performed under UV radiation (λ = 312 nm) 
using a video camera. 
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2.14.9 DNA Ligation 
For ligations, generally 500 ng of linearized, dephosphorylated pHORF3 vector were used 
with a 10-fold molecular excess of insert. The amount of insert needed to achieve this 10-
fold excess was calculated using the following formula. 
 ??????????? ? ?????????? ?????????????????? ? ?? 
 
Ligations were performed in total volumes of 60 µl using 3 U of T4 DNA Ligase (Promega). 
The samples were incubated overnight at 16°C and subsequently cleaned using the 
NucleoSpin Kit (Macherey Nagel). 
 
2.15 Biochemical Methods 
2.15.1 Bead Coupling Assay 
To enrich serum antibodies specific for salivary gland homogenate (SGH), 2 x 107 Carboxy 
Beads (Dynabeads, Invitrogen) were washed twice with 1 ml PBST and twice with 0.5 ml 
NaAc buffer (pH 4.5) by rotating for 5 min. Next 100 µl EDC and 100 µl NHS were added 
and the beads were rotated for 10 min at room temperature followed by another two wash 
steps with 0.5 ml NaAc buffer (pH 4.5) and 5 min of rotation each. 20 µg SGH (1 µg/106 
beads) were diluted in 200 µl NaAc buffer and incubated with the beads under rotation for 
20 min at room temperature. Subsequently, the beads were washed three times with 1 ml 
PBST followed by a 2 h rotation with 1 ml 100 mM ethanol amine. After this blocking step 
the beads were washed three times with 1 ml PBST, once with 1 ml PBS followed by an 
equilibration in 1 ml 0.1 M glycine/HCl pH 2.2. The beads were washed another three 
times with 1 ml PBS and incubated with 400 µl of a 1:1 serum-PBS dilution under rotation 
at 4°C over night. Next, the beads were washed three times with 1 ml PBS and the serum 
antibodies were eluted by incubation with 150 µl 0.1 M glycine/HCl pH 2.2 under rotation 
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for 15 min at room temperature. The supernatant was neutralized by addition of 45 µl 
0.5 M Tris-HCl pH 8 and brought to a total volume of 300 µl by adding PBS. The eluted 
antibodies were stored at 4°C until they were used in a subsequent capture or titration 
ELISA. 
2.15.2 Enzyme Linked Immunosorbent Assay (ELISA) 
2.15.2.1 Capture ELISA 
Capture antibody goat α-human IgG, polyvalent (Sigma I1761) was diluted 1:6700 with 
carbonate buffer and 100 µl were coated in each well of a MTP (Costar) overnight at 4°C. 
All wells were emptied and blocked with 350 µl 2% MPBST for 1.5 h at room temperature 
followed by three washing steps with PBST using an ELISA washer. Next, a dilution series 
of a protein N standard in 2% MPBST was prepared according to the supplier’s 
instructions and 100 µl of the respective dilution were filled into the wells and incubated at 
room temperature for 2 h. At the same time different volumes of eluted serum antibodies 
from the bead coupling assay diluted with 2% MPBST were also incubated in wells with 
immobilized capture antibody. After three washing steps with PBST using an ELISA 
washer, goat α-human IgG (Fc specific) peroxidase conjugated antibody (Sigma, A0170) 
was diluted 1:70,000 in 2% MPBST and aliquots of 100 µl were incubated in each well for 
1 h at room temperature followed by three washing steps with PBST using an ELISA 
washer. Finally 100 µl substrate solution (TMB-A and TMB-B, ratio 19:1) were added to 
each well. The staining reaction was allowed to take place for 5 to 20 min at room 
temperature and was stopped by addition of 100 µl 1 N H2SO4. 
2.15.2.2 Screening ELISA 
A screening ELISA was performed to analyze the interaction of patient serum with the 
antigen displaying phage obtained after three rounds of panning. Hence, mouse α-M13 
capture antibody (Progen) was diluted 1:400 in carbonate buffer and aliquots of 100 µl 
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were incubated in the wells of a MTP (Costar) overnight at 4°C. At the same time a serum 
pre-incubation mixture was set up as outlined in section 2.13.5.4 and incubated at 4°C 
overnight. All wells of the MTP were emptied and blocked with 2% MPBST for 1.5 h at 
room temperature followed by three washing steps with PBST using an ELISA washer. 
Next, 50 µl monoclonal antigen displaying phage, produced in MTPs (see section 2.13.5.6) 
were diluted with 50 µl 2% MPBST, filled into the wells and incubated at room temperature 
for 2 h. As negative controls 1 x 1010 Hyperphage (instead of antigen displaying phage) 
were added to the wells H3 and H6. After three washing steps with PBST using an ELISA 
washer 100 µl pre-incubated serum were filled into each well and incubated for 2 h at room 
temperature. After another three washing steps with PBST goat α-human IgG (Fc specific) 
peroxidase conjugated detection antibody was diluted 1:70,000 in 2% MPBST and 100 µl 
aliquots were filled into each well. As positive control mouse α-M13 peroxidase conjugated 
detection antibody (GE Healthcare) was diluted 1:40,000 in 2% MPBST and 100 µl were 
filled into wells H9 and H12 and incubated at room temperature for 1 h. After three 
washing steps with PBST using an ELISA washer 100 µl substrate solution (TMB-A and 
TMB-B, ratio 19:1) were added to each well. Staining reactions are allowed to take place 
for 5 to 20 min at room temperature and were stopped by adding 100 µl 1 N H2SO4. 
2.15.2.3 Titration ELISA 
200 ng salivary gland homogenate (SGH) from 18 h fed Ixodes scapularis nymphs diluted 
in carbonate buffer were immobilized in the wells of a microtiter plate (Costar) at 4°C 
overnight. Wells were blocked with 350 µl 2% MPBST for 1.5 h at room temperature 
followed by three washing steps with PBST using an ELISA washer. As negative controls, 
wells were solely blocked without the immobilization of SGH. Patient serum was diluted in 
2% MPBST (range of 1:10 to 1:10,000) and incubated in aliquots of 100 µl in each well for 
2 h at room temperature followed by three washing steps with PBST using an ELISA 
washer. Goat α-human IgG (Fc specific) peroxidase conjugated antibody (Sigma, A0170) 
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was diluted 1:70,000 in 2% MPBST and incubated in aliquots of 100 µl in each well for 1 h 
at room temperature followed by three washing steps with PBST using an ELISA washer. 
As an additional negative control the detection antibody was incubated in a well with 
immobilized SGH that had previously not been incubated with patient serum. Finally, 
100 µl substrate solution (TMB-A and TMB-B, ratio 19:1) were added to each well and 
staining reactions were allowed to take place for 5 to 20 min at room temperature before 
being stopped by adding 100 µl 1 N H2SO4. 
2.15.3 Protein analysis via SDS Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
The discontinuous SDS-PAGE was performed as outlined by Laemmli (Laemmli, 1970) 
under consideration of the modifications made by Righetti (Righetti, 1990) using a stacking 
gel to focus the proteins with a subsequent separation in a separating gel. The protein 
samples were mixed with SDS sample buffer followed by an incubation at 95°C for 5 min. 
After a short incubation on ice, the samples were run on a 12% polyacrylamide gel. The 
electrophoresis was performed at 200 V and 400 mA for 45 min. The composition of the 
stacking and separating gel is summarized in the following tables. 
Table 2-19: Recipe for a SDS-PAGE stacking gel 
Component Volume 
dH2O 1.00 ml 
Acrylamide solution 0.26 ml 
Tris 0.20 ml 
SDS solution 15 µl 
APS solution 15 µl 
TEMED 2 µl 
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Table 2-20: Recipe for a SDS-PAGE separating gel 
Component Volume 
dH2O 1.3 ml 
Acrylamide solution 1.6 ml 
Tris 1.0 ml 
SDS solution 40 µl 
APS solution 40 µl 
TEMED 2 µl 
 
2.15.4 Western Blot 
To transfer proteins previously separated in a SDS-PAGE to a PVDF membrane, a 
Western Blot was performed. Hence, a piece of filter paper was soaked in blotting buffer 
and placed on the blotting machine. On the filter paper the PVDF membrane, which was 
previously equilibrated in methanol, was placed followed by the gel and another piece of 
soaked filter paper. The protein transfer from the gel to the PVDF membrane was 
achieved by application of an electric field at 20 V and a maximum of 770 mA for 35 min. 
2.15.5 Immunostain 
After the transfer of proteins to the PVDF membrane, an immunostain was performed. 
First the membrane was blocked for 1 h in 2% MPBST on a rocker to avoid unspecific 
binding. Next, the membrane was incubated with goat α-human IgG (Fc specific) 
phosphatase conjugated (Dianova) diluted 1:5000 in 2% MPBST for 1 h at room 
temperature. After two wash steps with substrate buffer the membrane was incubated in 
10 ml substrate buffer supplemented with 100 µl NBT and 100 µl BCIP for 15 min at room 
temperature. The reaction was stopped by discarding the substrate solution and two 
subsequent wash steps with water. Finally, the membrane was dried between paper 
towels and documented using a digital scanner. 
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3 Results 
3.1 Analysis of human blood sera 
3.1.1 Determination of the abundance of antibodies specific for salivary gland 
homogenate (SGH) 
For this study, human blood sera from seven different individuals were analyzed to assess 
their titers of antibodies specific for salivary gland homogenate (SGH) of 18 hour fed 
Ixodes scapularis nymphs by titration ELISA. Prior to this analysis, patients were grouped 
as either tick bite sensitized by multiple tick bites or tick bite naïve. Grouping was 
performed according to the patient’s own statements and is summarized in the following 
table. 
Table 3-1: Summary of human patient sera available for this study and tick bite status according to the 
patient’s own statement 
Patient Tick bite status 
1 naïve 
2 sensitized 
3 sensitized 
4 sensitized 
10 naïve 
11 sensitized 
12 sensitized 
 
To analyze serum IgG binding to SGH at different serum dilutions, a titration ELISA was 
performed. As a negative control, serum at the lowest dilution of 1:10 was administered to 
blocked wells without SGH. 
Results depicted in Figure 3-1 reveal two important facts about the human blood sera 
analyzed. For all sera analyzed the signal decreased very rapidly with further dilution of 
the sample, indicating low titers of SGH specific antibodies of the IgG isotype. 
Secondly, it has to be noted that different sera reveal very different signal-to-noise ratios. 
A high background signal, referring to higher unspecific binding capacity, would be 
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undesirable in subsequent phage-display pannings since this might lead to amplification 
and selection of non-immunogenic phage clones. Among the serum samples analyzed, 
patient 2 and patient 12 exhibited the highest signal to noise ratio and appeared most 
promising for further analyses to identify immunogenic tick salivary proteins. Nevertheless, 
additional information verifying the presence of anti-SGH antibodies needs to be obtained. 
 
 
Figure 3-1: Titration ELISA to assay the reactivity of IgG present in human blood sera to SGH from 18 h fed 
I. scapularis nymphs 
 
3.1.2 Specific enrichment of anti-SGH antibodies 
To enrich antibodies from the human blood sera that are specific for SGH, a bead coupling 
assay was performed. In this approach, SGH obtained from 18 h fed I. scapularis nymphs 
was coupled to carboxy beads (Dynabeads, Invitrogen). To analyze the immobilization of 
SGH on the beads, the protein sample was visualized on an SDS-Polyacrylamide gel with 
subsequent silver staining before and after incubation with the magnetic beads. 
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Figure 3-2: SDS-PAGE of different amounts of SGH with subsequent silver staining, Lane M: Precision Plus 
unstained Protein Marker, Lane 1: 1 µg, lane 2: 500 ng, lane 3: 250 ng, lane 4: 100 ng, lane 5: 50 ng, lane 6: 
0 ng 
The silver staining (Figure 3-2) visualized different amounts of SGH on the SDS gel 
revealing the majority of proteins having a molecular mass between 25 kDa and 75 kDa. 
Importantly, it can be observed that the amount of 1 µg of SGH protein can be visualized 
very efficiently with this type of assay, thus providing the basis for the concentration of 
SGH needed for carboxy bead incubation. In the case of unsuccessful binding of SGH to 
the beads, the concentration in the supernatant needs to be high enough to reveal 
unsuccessful binding by silver gel analysis. Accordingly, the carboxy beads were 
incubated with 0.1 µg/µl SGH. 16 µl of the resulting supernatants were analyzed on a gel 
(Figure 3-3). Additionally, control beads were prepared without SGH. SDS-PAGE and silver 
staining analysis of the supernatants (Figure 3-3) confirmed successful binding of SGH to 
the carboxy beads since the supernatants showed no remaining protein. This suggests 
that the whole amount of SGH was coupled to the beads. 
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Figure 3-3: SDS-PAGE of supernatants from the immobilization of SGH to carboxy beads. Lane M: Precision 
Plus unstained Protein Marker, Lane 1+2: supernatant from SGH coupling, Lane 3+4: supernatant from control 
beads without SGH 
Following successful immobilization of SGH, carboxy beads were incubated overnight with 
human blood serum pooled from patients 2 and 12, then washed stringently and 
resuspended in PBS. From this bead suspension, distinct volumes were analyzed for 
antibody binding by ELISA using peroxidase conjugated α-human IgG (Fc specific) 
detection antibody. 
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Figure 3-4: ELISA on magnetic beads that were previously coupled with SGH and incubated with pooled 
human blood serum from patient 2 and 12. Control beads were solely blocked with ethanol amine prior to 
incubation with human blood serum. Human IgG bound to the beads were detected using an α-human IgG (Fc 
specific) HRP conjugated antibody. 
The ELISA performed directly on the magnetic beads (Figure 3-4) confirmed the 
accumulation of serum antibodies on beads previously coupled with SGH. Antibody 
binding to the control beads also could be observed, although to a far lesser extent, 
suggesting that antibodies specifically recognizing SGH were enriched on the SGH 
coupled beads. 
In the next step, the antibodies captured on the beads were eluted with an acidic solution 
of 0.1 M glycine/HCl, pH 2.2. After a short incubation, the supernatant was separated from 
the magnetic beads and neutralized. The resulting aqueous solution containing the eluted 
antibodies was analyzed on a silver gel as well as on a western blot. On an SDS gel 
(Figure 3-5) different amounts of eluate from either SGH coupled beads or control beads 
previously incubated with human serum were analyzed. In this SDS-PAGE, performed 
under reducing conditions, the bands for IgG antibodies were expected to run at 50 kDa 
(heavy chain) and 25 kDa (light chain), as clearly observed for the positive control. 
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Figure 3-5: Silver gel analysis of antibodies eluted from SGH coupled beads as well as control beads. 
Different volumes of eluate were applied to the gel. Lane M: Precision Plus unstained Protein Marker, Lane 1: 
16 µl eluate from SGH beads, Lane 2: 10 µl eluate from SGH beads, Lane 3: 5 µl eluate from SGH beads, 
Lane 4: 16 µl eluate from control beads, Lane 5: 10 µl eluate from control beads, Lane 6: 5 µl eluate from 
control beads, Lane (+): IgG positive control, 126 ng 
To detect the eluted antibodies, the characteristic IgG bands can most prominently be 
observed for the largest amounts of eluate applied to the gel (Lanes 1 and 4 in Figure 3-5). 
It also can be noted that the amount of antibodies eluted from the SGH coupled beads is 
larger than the amount eluted from the control beads. Western blot analysis of the same 
samples led to detection of IgG bands at the expected height of the 50 kDa marker band 
(Figure 3-6). 
In conclusion, the results obtained from the bead coupling assay validate its application for 
enriching antibodies from human blood sera that specifically bind salivary gland 
homogenate from 18 hour fed I. scapularis nymphs. The assay can be used to directly 
analyze the content of SGH specific antibodies in various serum samples. 
To justify the subsequent use of human blood sera in phage display pannings for 
identifying immunogenic tick salivary proteins, the bead coupling assay was used to verify 
the presence of anti-tick salivary protein antibodies in the serum samples. Due to 
limitations in the availability of SGH, only two different sera could be analyzed. Thus, 
 42 
 
patient 2 and patient 12 were selected, according to the findings from the titration ELISA 
(Figure 3-1). 
 
 
Figure 3-6: Wetsern blot analysis of antibodies eluted from SGH coupled beads as well as control beads. 
Different volumes of eluate were applied to the gel. Lane M: Precision Plus Dual Color Protein Marker, Lane 1: 
16 µl eluate from SGH beads, Lane 2: 10 µl eluate from SGH beads, Lane 3: 5 µl eluate from SGH beads, 
Lane 4: 16 µl eluate from control beads, Lane 5: 10 µl eluate from control beads, Lane 6: 5 µl eluate from 
control beads, Lane (+): IgG positive control, 126 ng. After blotting the antibodies were detected using an α-
human IgG (Fc specific) peroxidase conjugated detection antibody. 
 
3.1.3 Analysis of selected human blood sera for specific anti-tick antibodies 
The bead coupling assay outlined above was repeated using sera from patients 2 and 12, 
respectively. The amount of antibodies eluted from SGH coupled- and control beads after 
incubation with serum from either patient 2 or patient 12 was determined by a capture 
ELISA and compared to a Protein N Standard. Additionally, the IgG content of the crude 
serum was determined. Results of the capture ELISA are summarized in Table 3-2. 
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Table 3-2: Determination of the IgG concentrations of crude serum, eluate from SGH coupled beads and 
eluate from control beads of patients 2 and 12. 
 Antibody Concentration of 
Serum Crude serum 
Eluate from SGH 
coupled beads 
Eluate from control 
beads 
Patient 2 9.39 mg/ml 85.63 ng/ml 42.82 ng/ml 
Patient 12 11.04 mg/ml 375.50 ng/ml 104.07 ng/ml 
 
Determining exact concentrations of IgG antibodies permitted normalization of the 
amounts of the respective antibodies applied in a repeated titration ELISA on SGH. This 
assay was used to reveal the specific binding capacity of enriched antibodies from the 
SGH coupled beads as compared to the crude serum and the eluate from the control 
beads. This assay (Figure 3-7) confirmed the successful enrichment of anti-SGH antibodies 
from the sera of patients 2 and 12. When the same amount of antibodies from either crude 
serum or the control eluate was applied to SGH, no significant signal could be observed. 
Thus, it can be concluded that both sera analyzed do contain SGH specific antibodies. 
This finding justifies use of the sera for subsequent phage display screenings to identify 
immunologically relevant antigens. 
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Figure 3-7: Titration ELISA of normalized crude serum as well as eluted antibodies from SGH coupled beads 
and control beads from patient 2 (A) and patient 12 (B) on salivary gland homogenate 
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3.2 Analysis of an antigen library from adult Ixodes scapularis 
3.2.1 Construction of an antigen library from adult Ixodes scapularis 
For the construction of an antigen library based on transcripts from salivary glands of adult 
I. scapularis, female ticks were allowed to feed on a rabbit host for 18 h. After removing 
ticks from the rabbit, tick salivary glands were dissected followed by mRNA extractions 
and conventional cDNA synthesis using random hexamer primers. The blunt ended cDNA 
was analyzed on an agarose gel and subsequently cloned into the phagemid vector 
pHORF3 to yield the library. E. coli TOP10F’ were transformed with this library by 
electroporation. After determination of the primary diversity, the library was packaged into 
phage particles using the helperphage M13K07ΔgIII (Hyperphage) to enrich for open 
reading frames. 
 
Figure 3-8: Based on mRNA from salivary glands of 18 h fed adult I. scapularis cDNA was synthesized using 
random hexamer primers (A). This cDNA was blunt ended, cloned into pHORF3 and E. coli TOP10F’ were 
transformed with this library; from the resulting colonies 20 random clones were picked and analyzed in a 
CPCR, (B) M: Marker, (-): empty pHORF3 as negative control 
Examining the double-stranded cDNA on an agarose gel (Figure 3-8 (A)) showed a smear 
ranging from 200 bp to approximately 1500 bp. This broad distribution of cDNA fragments 
satisfies criteria for antigen library construction with respect to yielding a high diversity of 
different antigens. A broader the distribution of different inserts indicates higher diversity of 
the library. Based on this, the insert sizes of 20 randomly-picked clones were analyzed  
and revealed a broad distribution of different insert sizes (Figure 3-8 (B)). Also, nearly 100% 
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of the clones appeared to carry inserts, further fulfilling the criteria for antigen library 
construction. 
To further assess the characteristics of the library, some 20 random clones were subjected 
to sequence analysis to provide insight into what is encoded within the library. A BLASTn 
analysis using these sequences revealed that most hits referred to database entries from 
Ixodes scapularis designated as “tandem repeats”, and no known function could be linked 
to those sequences. Furthermore, the library contained some rRNA sequences, which was 
unwanted due to their non-protein-coding nature. There were some sequences that 
encoded putative salivary proteins, giving the library its significance. The most important 
characteristics to evaluating the quality of the library are summarized in Table 3-3. 
Table 3-3: Summary of important characteristics to evaluate the quality of the antigen library derived from 
salivary glands of adult ticks 
Ticks 
needed 
Diversity 
Titer after 
packaging 
Effort Insert (%) Random sequencing 
500 - 700 1 x 106 
5 x 109 to 
2 x 1011 
high >95% 
Many “tandem repeat” 
sequences 
Some rRNAs 
 
3.2.2 Panning of an antigen library from adult Ixodes scapularis 
To identify immunogenic polypeptides from tick salivary glands of adult I. scapularis, the 
antigen library was screened against human blood serum. For this purpose, the library 
discussed above was packaged into phage particles that display the respective salivary 
protein on their surface. Primary packaging of the library with Hyperphage yielded a titer of 
5 x 109 CFU/ml. A total of three panning rounds was performed to enrich for immunogenic 
peptides. The pannings were performed in MTPs in which IgG antibodies from patient sera 
were captured, followed by incubation with the antigen displaying phage and stringent 
washing. Prior to their application, the human blood sera had been pre-incubated with 
E. coli cell lysate and Hyperphage to prevent enrichment of unspecific phage due to 
antibodies recognizing the phage particle itself and not the peptide displayed. Over the 
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course of the three panning rounds, the titer of eluted phage after each round was 
monitored for an indication of successful enrichment. 
The first two pannings performed with the antigen library derived from adult I. scapularis 
salivary glands resulted in titers of less than 10³ eluted phage after the first panning round. 
Consequently, these pannings were cancelled. Packaging of the library into phage 
particles was repeated and yielded an increase in titer of almost two orders of magnitude 
as compared to the first packaging (also see Table 3-3). 
The newly packaged library was used for a new panning and the titers of eluted phage 
were monitored after each panning round (Figure 3-9). The titers of eluted phage increased 
with subsequent panning rounds, suggesting an enrichment of phage particles displaying 
potentially immunogenic peptides. 
 
 
Figure 3-9: Increasing titers of eluted phage from the adult tick antigen library after each panning round. The 
increase of eluted phage after each round indicates an enrichment of specific phage clones. 
After the third panning round, 94 random clones were picked and grown in a microtiter 
plate (MTP) to subsequently produce monoclonal antigen-phage for a screening ELISA. 
The wells H3 and H6 remained empty as negative controls. Clones inoculated into wells 
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H9 and H12 were later on not used for screening with patient serum but as positive 
controls for a successful phage production. 
A screening ELISA performed to test for immunogenic polypeptides displayed on the 
phage particles was performed in two different ways. In the first approach, monoclonal 
antigen-phage were immobilized in the wells of a MTP directly. Subsequently, pre-
incubated patient serum was added to the phage. After stringent washing, human 
antibodies were detected by application of peroxidase -conjugated α-human IgG (Fc 
specific) antibody. 
In the second approach, the monoclonal phage particles were not coated directly to the 
wells of a MTP but instead were captured using a monoclonal mouse α-M13 antibody. The 
remaining procedure of the incubation and detection was essentially the same. 
For negative controls in the screening ELISA, Hyperphage was added to the respective 
wells (H3 and H6) instead of monoclonal antigen-displaying phage particles. Thus, the 
only difference between the negative control and the experimental approaches was the 
display of the respective tick polypeptide on the phage surface. As positive control, the 
presence of phage particles was assayed by applying an peroxidase-conjugated α-M13 
detection antibody. Positive controls were not incubated with human blood serum. 
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Figure 3-10: Results of the screening ELISA from the randomly picked clones resulting from the third panning 
round of the antigen library derived from adult I. scapularis salivary glands. In (A) the phage particles were 
coated directly whereas in (B) the phage particles were captured. Negative Control: Hyperphage; Positive 
control: detection of phage particles 
Results of the screening ELISA revealed no immunogenic peptides displayed on any of 
the phage analyzed (Figure 3-10). However, production and immobilization of the 
monoclonal antigen-phage was successful as confirmed by the positive control. One 
finding that can be derived from the experiments shown is that there is a difference for this 
assay with regards to the comparison of directly coated or captured phage. In the case of 
captured phage particles, it can be noted that the general background signal is lower. This 
phenomenon also was observed previously (Havlik, personal correspondence) and is 
confirmed here. Consequently, for all screening ELISAs performed hereafter, the phage 
particles were always captured. To solve the issue of unsuccessful panning the 
component that was to be changed most easily was addressed and a new antigen library 
was constructed. 
 50 
 
3.3 Analysis of an antigen library from nymphal Ixodes scapularis 
3.3.1 Construction of an antigen library from nymphal Ixodes scapularis 
Since nymphal ticks are of higher relevance with respect to transmission of pathogens, 
primarily due to their smaller size, an antigen library based on nymphal tick salivary glands 
was constructed. The general procedure was the same as for the adult antigen library 
(section 3.2.1), however, a different strategy for cDNA synthesis was chosen to overcome 
a limitation in the availability of salivary gland mRNA.  
Ixodes scapularis nymphs were allowed to feed on a mouse or hamster host for 18 hours. 
After ticks were pulled off their host, tick salivary glands were dissected and subjected to 
mRNA extractions. The mRNA extracted in this process was used to synthesize double-
stranded cDNA following the protocol for SMART cDNA synthesis (Clontech, CA). Briefly, 
an oligo(dT) Primer with an adapter is used together with a reverse transcriptase. The 
reverse transcriptase used needs to have two advanced activities. First, terminal 
transferase activity is necessary which leaves a small number of cytosine residues at the 
3’ end of the newly synthesized first strand cDNA. Second, template switching activity is 
needed. The reaction mixture contains a second primer comprised from 5’ to 3’ of the 
adapter sequence followed by a small number of guanidine residues. This primer 
recognizes the C residues synthesized by the reverse transcriptase and subsequently acts 
as new template to add the adapter sequence to the first-strand cDNA. Finally, a PCR can 
be performed using a specific primer for the adapter sequence which allows amplification 
of all transcripts. The SMART cDNA that was synthesized was visualized on an agarose 
gel. 
This protocol, however, leads to full length transcripts containing the stop codon as well as 
5’ UTR and 3’ UTR, all of which are unwanted for subsequent cloning into pHORF3. To 
avoid these issues, the SMART cDNA was subjected to a restriction enzyme digest using 
the three blunt-end cutters AfeI, AluI and CviKI-1, making the digested cDNA was directly 
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available for cloning. After cloning into pHORF3, the resulting antigen library was 
transformed into E: coli TOP10F’ by electroporation. After determining the primary 
diversity, the library was packaged into phage particles using the helperphage 
M13K07ΔgIII (Hyperphage) to enrich for open reading frames. 
 
Figure 3-11: Based on mRNA from salivary glands of 18 h fed I. scapularis nymphs, cDNA was synthesized 
following the SMART cDNA synthesis protocol (A). This cDNA was subject to a restriction enzyme digest, 
cloned into pHORF3 and E. coli TOP10F’ were transformed with this library; from the resulting colonies 20 
random clones were picked and analyzed in a CPCR, (B) M: Marker, (-): empty pHORF3 as negative control 
Examination of the SMART cDNA visualizes the size of cDNA fragments ranging from 
200 bp to more than 1500 bp (Figure 3-11 (A)) revealing a satisfying distribution of different 
fragments. Additionally, using the SMART protocol, it was possible to synthesize µg 
amounts of cDNA from only ng amounts of mRNA, overcoming the limitation of low 
availability of the desired starting material. The distribution of different insert sizes after 
cloning into pHORF3 was analyzed by CPCR and subsequent agarose gel electrophoresis 
(Figure 3-11 (B)). This analysis revealed a satisfying distribution of different inserts as well 
as an insert percentage of close to 100%. Furthermore, the clones also were subjected to 
sequence analysis. Performing a BLASTn analysis using the sequences obtained from 
randomly picked clones, most sequences could be linked to previously annotated 
database entries of Ixodes scapularis salivary proteins. None of the sequences analyzed 
referred to the “tandem repeat” entries encountered when analyzing the antigen library 
derived from adult ticks (see section 3.2.1). Also, no sequences referring to rRNAs were 
found, confirming the specific reverse transcription of poly (A) tailed RNAs only. In 
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conclusion, the parameters analyzed to evaluate the quality of the library appear to be very 
promising. An overview of the important parameters is given in Table 3-4. 
Table 3-4: Summary of important characteristics to evaluate the quality of the antigen library derived from 
salivary glands of nymphal ticks 
Ticks 
needed 
Diversity 
Titer after 
packaging 
Effort Insert (%) Random sequencing 
~50 1 x 106 2 x 1011 low >95% 
Mostly annotated tick 
sequences 
 
3.3.2 Panning of an antigen library from nymphal Ixodes scapularis 
3.3.2.1 Panning using pooled human blood sera 
To identify immunogenic tick salivary proteins, three rounds of panning were performed 
using the nymphal antigen library and pooled human blood sera from all patients classified 
as sensitized (see Table 3-1). The pooled serum was pre-incubated in a mixture containing 
Hyperphage and E. coli cell lysate to prevent enrichment of unspecific phage due to 
antibodies recognizing the phage particle itself and not the peptide displayed. Over the 
course of the three panning rounds, the titers of eluted phage after each round were 
monitored to give an indication of successful enrichment (Figure 3-12). Two pannings were 
performed in parallel. 
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Figure 3-12: Development of the titers of eluted phage from the nymphal antigen library after each panning 
round. The increase of eluted phage after each round indicates the enrichment of specific phage clones. 
For both pannings, titers increased with subsequent rounds indicating successful 
enrichment of potentially significant clones. To identify immunogenic peptides displayed by 
phage, a screening ELISA was performed. After the third panning round 94 random clones 
from each panning performed were picked and grown in MTPs to produce monoclonal 
antigen-displaying phage. The results of the screening ELISAs are shown in Figure 3-13. 
It has to be noted that, despite the promising increase in titers of eluted phage after each 
panning round, the screening ELISA did not reveal a positive clone in either of the two 
pannings performed. Moreover, none of the signals obtained was significantly higher than 
that of the negative control. As with the adult antigen library, unsuccessful production of 
the monoclonal phage can be excluded to be the issue, since the positive control gave a 
strong signal. 
Two critical points for ensuring a successful panning are the amount of anti-tick specific 
antibodies in the sera as well as the quality of the antigen library. Since with the nymphal 
antigen library all parameters considered to evaluate the quality of the library appear to be 
very good (see Table 3-4), it suggested that changes in the use of human blood sera might 
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lead to a successful panning. Thus, a second panning was performed using individual 
instead of pooled sera. 
 
Figure 3-13: Screening ELISAs of the randomly picked clones after the third panning round. Panning was 
performed using the nymphal antigen library and pooled human blood serum from patients previously classified 
as sensitized. Negative Control: Hyperphage; Positive control: detection of a random antigen displaying phage 
using an α-M13 peroxidase conjugated antibody. 
 
3.3.2.2 Panning using single human blood sera 
To identify immunogenic tick salivary proteins, an alternative panning strategy was utilized 
in which human blood serum from only one individual was used instead of a serum pool. 
Besides this variation, the strategy pursued was essentially the same as outlined 
previously. For the following analyses sera from patients 2, 11, 12 and patient X were 
used. As outlined for all previous pannings performed, the titers of eluted phage after each 
panning round were monitored (Figure 3-14). In all cases a prominent increase in eluted 
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phage can be observed, suggesting the successful enrichment of phage particles 
displaying potentially immunogenic peptides. 
 
Figure 3-14: Development of the titers of eluted phage from the nymphal antigen library after each panning 
round using individual human blood sera. The increase of eluted phage after each round indicates the 
enrichment of specific phage clones. 
As outlined for previous pannings, after the third panning round, 94 randomly picked 
clones were grown in MTPs to produce monoclonal phage particles displaying tick salivary 
peptides. The resulting monoclonal phage were used to perform a screening ELISA to 
assess for successful enrichment of phage displaying immunogenic peptides. 
Results of the screening ELISAs are shown in Figure 3-15. While the pannings performed 
with sera from patient 11 (Figure 3-15 (B)) and patient X (Figure 3-15 (D)) resemble the 
results seen in all previously performed screening ELISAs, pannings performed with sera 
from patient 2 (Figure 3-15 (A)) and patient 12 (Figure 3-15 (C)) led to clones with signal 
intensities higher than that of the negative control containing Hyperphage. Signals being 
one and a half to twice as high as the signal of the negative control can be considered as 
potential clones of interest and eight clones from the panning with patient 2 serum as well 
as five clones from the panning with patient 12 serum were selected and subject to 
sequence analysis. The sequences obtained were analyzed using the BLASTn algorithm. 
The eight clones obtained from patient 2 serum revealed four different inserts. The most 
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abundant clone which occurred four times among the eight clones analyzed was carrying 
the genetic information for a fragment of Metalloprotease 1 from I. scapularis but also had 
significant similarity to metalloproteases from I. pacificus and I. ricinus. The five clones 
obtained from panning with patient 12 serum revealed three different inserts. The results 
are summarized in Table 3-5. 
Table 3-5: Summary of the sequencing analysis of positive clones obtained from panning with individual 
patient sera. The inserts found were subject to a BLASTn analysis to determine the nature of the peptide 
displayed on the phage. 
Derived 
from 
Patient 
Frequency 
Insert 
size 
Accession 
Number 
Description Identity 
2 1/8 - - Sequencing failed - 
2 1/8 64 bp XM_002406537.1 
Ixodes scapularis DNA 
ligase, putative, mRNA 
100% 
2 4/8 118 bp AY264367.1 
Ixodes scapularis salivary 
gland metalloprotease 
mRNA 
92% 
2 1/8 43 bp XM_002403042.1 
Ixodes scapularis 60S 
ribosomal protein L14, 
putative mRNA 
100% 
2 1/8 79 bp XM_002416616.1 
Ixodes scapularis alpha 
tubulin, mRNA 
99% 
12 2/5 - - Sequencing failed - 
12 1/5 43 bp XM_002403042.1 
Ixodes scapularis 60S 
ribosomal protein L14, 
putative, mRNA 
100% 
12 1/5 139 bp XM_002434300.1 
Ixodes scapularis E3 
ubiquitin protein ligase 
Bre1, putative, mRNA 
99% 
12 1/5 79 bp XM_002416616.1 
Ixodes scapularis alpha 
tubulin, mRNA 
99% 
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Figure 3-15: Screening ELISAs of the randomly picked clones after the third panning round. The pannings 
were performed using the nymphal antigen library and individual human blood sera. (A) Patient 2, (B) Patient 
11, (C) Patient 12, (D) Patient X; Negative Control: Hyperphage; Positive control: detection of a random 
antigen displaying phage using an α-M13 peroxidase conjugated antibody. 
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3.3.2.3 Verification of binders identified in the pannings 
To verify binders that were identified in pannings with individual patient sera and listed in 
Table 3-5, the respective phage were newly packaged and subject to a repeated ELISA 
using the respective patient serum. As outlined previously, the patient sera were pre-
incubated with E. coli cell lysate and Hyperphage. As negative control, Hyperphage were 
captured by an α-M13 antibody instead of antigen displaying phage particles. The clones 
that could not be sequenced successfully were designated as “unknown” and included in 
the verifying ELISA. The results of the verifying ELISA are shown in Figure 3-16. For all 
clones analyzed, it can be observed that the signal is significantly stronger than that of the 
negative control. However, signal intensities in general are comparably low as they were 
throughout all previously performed analyses. 
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Figure 3-16: ELISA to verify the specific recognition of antigen displaying phage identified in Section 3.3.2.2 by 
the respective patient serum; (A) Patient 2; (B) Patient 12; Hyperphage serves as negative control as 
previously outlined for the screening ELISA analyses. 
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4 Discussion 
Due to their capacity for pathogen transmission, ticks pose significant risks to humans, 
domestic animals and cattle, resulting in public health concerns as well as economic 
losses (Wikel and Alarcon-Chaidez, 2001). Current treatments to relieve tick burdens in 
endemic areas are mostly based on the application of acaricides. This strategy, however, 
has negative impacts on the environment and agriculture. Additionally, certain tick species 
quickly develop insecticide resistance (Willadsen, 2004). Another strategy gaining greater 
attention over the past two decades is the idea of anti-tick vaccination (de la Fuente et al., 
2007b; Nuttall et al., 2006). Based on the phenomenon of acquired tick bite immunity 
(Trager, 1939), vaccination with molecules present in tick saliva appears to be most 
promising when pursuing an anti-tick vaccination approach (Willadsen, 2004). 
The goal of this study was to identify Ixodes scapularis salivary antigens that might serve 
as novel vaccine candidates for humans. To identify these proteins, a phage display 
approach was employed. The screening was designed to identify I. scapularis salivary 
antigens that are recognized by antibodies present in human blood sera. 
 
4.1 Analysis of human blood sera 
Human blood sera from seven different individuals were available for this study. These 
patients had been grouped as being either tick bite sensitive or naïve according to their 
own statement. This first classification of the serum samples already states a critical point 
when evaluating the sera. Individuals previously bitten by ticks can provide sound 
information that they have been in close contact with ticks, thereby imparting significance 
to their sera with respect to the presence of anti-tick antibodies. Conversely, individuals 
reporting to be tick-bite naïve may still have been bitten by ticks, even multiple times, but 
may never have recognized it. An additional issue with the sera used in this study is that it 
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is unknown when sensitized patients had last been in contact with ticks. This is an 
important factor for the presence of anti-tick specific antibodies in the serum, since titers 
decrease after prolonged elapsed time with no tick contact. A titration ELISA was 
performed to further assess the reactivity of serum antibodies with SGH. Results obtained 
from this assay did not produce a clear distinction between tick bite sensitive and tick 
naïve patients, leading to a major limitation: the lack of a validated serum negative control. 
In addition to the indistinguishability between tick bite sensitive and naïve blood sera, low 
titers of serum antibodies specific for SGH, in general, were another limitation. Following 
examination by the titration ELISA the most promising sera were obtained from patients 2 
and 12, especially due to their relatively high signal-to-noise ratios. Continued analyses of 
these sera using the bead coupling assay to enrich SGH specific antibodies and the 
subsequent titration ELISA with these enriched antibodies on SGH confirmed the presence 
of SGH specific antibodies. Nevertheless, low antibody titers in general were a limitation to 
the experimental design. 
The study presented here is the first investigation aiming to identify immunogenic tick 
salivary proteins using human immune sera. All studies reviewed in the literature used 
sera from laboratory animals or cattle. The advantage of laboratory animals becomes clear 
when considering that rabbits for example can be challenged with ticks multiple times in 
intervals of two weeks and that serum samples can be taken at the peak point of an 
antibody response (Das et al., 2001; Narasimhan et al., 2007a; Schuijt et al., 2011b). Such 
highly reactive sera cannot be obtained so easily from humans, somewhat limiting the 
usability of human sera. Nevertheless, the observed presence of SGH specific antibodies 
together with the patient’s reports of immune responses to tick bites, justifies use of the 
serum samples available. 
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4.2 Construction of salivary gland antigen libraries 
Salivary gland antigen libraries constructed in this work are based on mRNA from the 
salivary glands of 18 hour fed I. scapularis. Since these tissues are very small, especially 
during early stages of the feeding process, mRNA yields are a limiting factor. Even though 
the salivary glands grow and change in morphology during the feeding process (Kaufman, 
1989), the early time points are of higher significance with respect to identifying potential 
vaccine candidates (Narasimhan et al., 2007a). 
Two different approaches for cDNA synthesis from salivary gland mRNA were utilized in 
this study. First, conventional cDNA synthesis was used to construct an antigen library 
based on adult ticks. In this approach the amount of cDNA synthesized is approximately 
equal to the amount of mRNA available making this strategy very laborious with respect to 
the collection of starting material. This is also the primary reason why adult ticks were 
used, since their salivary glands are significantly larger than those of nymphal ticks. For 
synthesis of a sufficient amount of cDNA a total of 500 to 700 adult ticks were dissected. A 
comparable study reported dissection of more than 1000 nymphs in order to construct an 
antigen library (Schuijt et al., 2011b). The resulting cDNA was analyzed by agarose gel 
electrophoresis revealing a sufficiently broad distribution of different fragments (Figure 3-8). 
In this analysis a distinct band at approximately 450 bp was very prominent. A possible 
explanation for this finding could be that the reverse transcriptase used for cDNA synthesis 
has an optimum for synthesizing fragments of this size. This single band could still be 
comprised of different fragments even though they have the same size. 
Sequence analysis of random clones from this library revealed inserts encoding rRNA 
among other sequences. This result reflects the unspecific reverse transcription of any 
kind of RNA present in the reaction mixture, making this protocol susceptible to 
contamination. It also demonstrates that, even though an mRNA extraction kit was used, 
some rRNA contamination occurred diluting the diversity of the library. 
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The second approach, using a SMART cDNA synthesis protocol, proved to be much more 
efficient. Salivary glands of only 50 nymphs were required in order to synthesize large 
amounts of cDNA. The distribution of different fragments obtained with this approach was 
sufficiently broad. Furthermore, no rRNA contamination was observed, probably due to the 
use of an oligo (dT) primer, which creates a second, strong selection for poly (A) tailed 
RNAs. SMART cDNA synthesis has been used previously in tick salivary gland 
transcriptomics (Ribeiro et al., 2006; Valenzuela, 2002; Valenzuela et al., 2002) and the 
use of such cDNAs in phage display approaches also has been addressed previously 
(Georgieva and Konthur, 2011). These obvious advantages, however, should not belie the 
fact that there are some disadvantages of this method as well. Utilization of the two 
adapter primers and subsequent PCR amplification could introduce a bias towards certain 
transcripts. Additionally, the full-length transcripts need to be fragmented which was 
achieved by the action of three different restriction enzymes. This step introduces a bias to 
the cDNA fragments since occurrence of the restriction sites will not be completely 
random. Finally the ratio of highly abundant to less abundant transcripts is unlikely to be 
preserved during the PCR amplification step. 
In conclusion, according to the parameters employed to evaluate the two antigen libraries, 
SMART cDNA synthesis proved to be the better strategy to construct a library of desired 
quality. 
 
4.3 Screening for immunogenic peptides 
Successful phage display screenings seeking to identify immunogenic proteins rely 
primarily on two factors. First, the antigen library needs to be of good quality with respect 
to diversity and display of antigenic peptides. Second, the availability of antibodies used to 
probe the library is crucial. The low titers of anti-tick antibodies in the human blood sera 
present a major limitation. The panning strategy pursued in this study has been utilized 
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successfully in previous reports (Kugler et al., 2008; Meyer et al., 2012; Naseem et al., 
2010), however, convalescent sera from recently infected animals provided higher 
antibody titers in those studies. 
For the study presented here, two different ways of employing human blood sera were 
assayed. When all sera previously classified as tick sensitized were pooled, screening with 
either of the two antigen libraries constructed was unsuccessful. This could be explained 
by the idea that each of the sera contains tick-specific antibodies. However, different 
individuals might recognize different salivary antigens. In this case, pooling of the sera 
further dilutes the tick-specific antibodies, thus impeding successful enrichment of the 
corresponding antigens. None of the results obtained in the study presented here 
contradict this notion. The idea that serum pooling and subsequent antibody dilution could 
be a limitation is further underlined by the fact that pannings, using individual patient sera 
led to identification of immunogenic salivary proteins. Another critical point of the 
experimental setup is performance of the screenings as library-vs-library approaches in 
which two complex mixtures are screened against each other. This double-sided high 
complexity limits the number of possible specific interactions exacerbating identification of 
immunogenic polypeptides. 
It is noteworthy that, despite the fact whether or not a panning was judged successful, the 
titers of eluted phage after each panning round increased. Thus, in all cases phage have 
been enriched, however, this includes enrichment of unspecific phage particles as shown 
in the respective screening ELISAs. This effect might be due to remaining serum 
antibodies that recognize phage coat proteins even though the sera were pre-incubated 
with Hyperphage. Presence of such antibodies also would explain the general background 
signal in all screening ELISA analyses. Another explanation could be that enriched phage 
particles display peptides promoting some sort of selection advantage. Factors influencing 
this advantage could be an increased infectivity of the phage due to the peptide displayed, 
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thereby leading to a higher production rate of a specific clone. Additionally, unspecific 
binding might be caused by interactions between phage and other protein components 
present in the screening setup (Vodnik et al., 2011). This last point is of special 
significance when considering the very high background signals of the different sera. 
Interestingly, antigens identified in this study resulted from screenings with those sera that 
previously had been mentioned to reveal the best signal-to-noise ratios, confirming that 
general serum stickiness is an important criterion. 
 
4.4 Metalloprotease 1 and its homologs 
Among the salivary proteins identified in this work, the metalloprotease appears to be of 
greatest interest. This is primarily due to the fact that it is the only extracellular and actively 
secreted protein recognized by the human immune sera. 
Previous reports state that Metalloprotease 1 (MP1) of Ixodes scapularis is synthesized as 
a pre-pro-enzyme containing a signal peptide as well as a pro-peptide which are both 
cleaved off in order to get the active protein (Francischetti et al., 2003). MP1 has a 
theoretical molecular weight of 37 kDa, a conserved zinc-binding domain as well as 12 
highly conserved cysteine residues. Furthermore, it has been reported to have 
fibrin(ogen)lytic activity as well as gelatinase activity (Francischetti et al., 2003). Thus, this 
enzyme is hypothesized to act as an anti-hemostatic in tick saliva. Interestingly, it has 
been noted that Borrelia spirochetes upregulate expression of metalloproteases in their 
vertebrate hosts, potentially enhancing degradation of extracellular matrix proteins to 
improve spreading of the pathogen (Gebbia et al., 2001). This fact presents one possible 
route on which tick feeding can actively promote pathogen transmission, raising the 
significance of the observation made in this study to suggest MP1 as a novel vaccine 
candidate. 
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Figure 4-1: Sequence alignment of protein sequences of the peptide displayed on the phage identified (Insert) 
and the protein sequences of metalloproteases from I. scapularis (AY264367.1), I. pacificus (AY674268.1) and I. 
ricinus (AM747806.1).  
 
Increasing the potential of MP1 as an anti-tick vaccine is the finding that the protein has 
close homologs in other tick species such as I. pacificus and I. ricinus. The sequence 
alignment shown in Figure 4-1 demonstrates the close homology between metalloproteases 
of these tick species. Additionally, the immunogenic peptide displayed on the phage in this 
work, reveals high identity with all three proteins, raising hopes for a more universal, multi-
species vaccine candidate (Parizi et al., 2012). 
The insert identified in the phage display screening covers a sequence which coincides 
exactly with the beginning of the cysteine rich region and just nine amino acids away from 
the zinc-binding domain. Binding of an antibody to this region thus might interfere in 
binding of the metalloprotease to proteins of the extracellular matrix, as this has been a 
suggested function of the cysteine rich region (Francischetti et al., 2003). Furthermore, 
binding of an antibody this close to the active site might interfere with the catalytic function 
of the enzyme, for example by steric hindrance of substrate binding. 
Of utmost interest for the evaluation of MP1 as a novel vaccine candidate are reports 
about salivary gland metalloproteases in I. ricinus, termed Metis. (Decrem et al., 2008a; 
Decrem et al., 2008b). Metis 1 is a close homolog to I. scapularis MP1 (see Figure 4-1). In 
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the studies presented by Decrem et al., the vaccination potential of Metis 1 was evaluated 
and showed a negative effect on weight gaining and oviposition in ticks that fed on 
vaccinated hosts. Vaccination with Metis 1 elicited an antibody response against Metis 1 
and 2 in rabbits. Furthermore, knock-down of Metis 1 by RNA interference led to an 
increased mortality rate in ticks (Decrem et al., 2008a; Decrem et al., 2008b). Since the 
Metis proteins were analyzed because rational considerations suggested them as 
immunologically interesting enzymes, the findings in this work confirmed the potential 
relevance of metalloproteases in anti-tick vaccination. 
This relevance is further underlined by vaccination experiments with a metalloprotease 
from Haemaphysalis longicornis in rabbits even though there is little sequence identity to 
metalloproteases from Ixodes species (Imamura et al., 2009). 
 
4.5 Further binders identified 
Except for the metalloprotease, all other binders identified in this work are intracellular 
proteins. While it might seem appropriate to exclude non-secreted proteins as potential 
immunogenic targets, host contact with these proteins is still possible and a tick ribosomal 
protein has recently been suggested as a vaccine candidate (Rodriguez-Mallon et al., 
2012). Salivary glands change dynamically in gene expression and morphology during 
feeding (Kaufman, 1989) with cell proliferation as well as cell death as expected outcomes. 
From these cells, intracellular components can leak into the surrounding fluids and thus, 
reach the host where an adaptive immune response can be initiated. 
However, as determined by sequence analysis, the likelihood that all binders identified are 
artifacts appears significant. This is primarily due to the fact that none of the inserts are 
incorporated into the vector in the right frame. In the case of DNA ligase, ribosomal protein 
and ubiquitin ligase, a high identity sequence exists in the opposite direction to the coding 
sequence of the signal peptide and the gene encoding pIII. Additionally, none of the inserts 
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contain a stop codon in the +3 reading frame, explaining why the respective phage could 
be packaged.  
In the case of α-tubulin, the orientation of the insert is correct; however the reading frame 
is shifted as compared to the surrounding genetic elements of the vector. Furthermore, the 
insert does not reveal a stop codon in any of the possible reading frames and the 
corresponding tubulin sequence has a 100% identity to human  
α-tubulin. This last finding, especially, excludes α-tubulin as a significant binder. 
Sequence analysis of the peptides actually displayed on the phage particles revealed two 
interesting facts. First, three of the four sequences contain a cysteine residue in the C-
terminal half of the peptide. Recent findings report the coupling of protein toxins to 
antibodies via cysteine residues of the hinge region (M. Hust, personal correspondence) 
giving room for speculations regarding the occurrence of cysteine residues in the peptides 
displayed and their selection by serum antibodies. 
Second, three of the four sequences show large hydrophobic stretches and only few 
hydrophilic areas when analyzed in a hydrophobicity plot (data not shown). Thus, one 
could speculate that the respective peptides have been selected due to unspecific 
hydrophobic interactions. This also could be brought into context again with the general 
stickiness of the human blood sera. Furthermore, due to the limited number of desired 
immunogenic interactions (as outlined above) the possible number of unspecific 
interactions is increased, leading to an enrichment of the undesired clones found in this 
study. 
 
4.6 Conclusion 
The study presented here was seeking to identify salivary antigens from Ixodes scapularis 
that were recognized by antibodies from human blood sera utilizing a phage display 
approach. In order to perform a successful screening two main limitations had to be 
 69 
 
overcome. First, the low abundance of serum antibodies specific for salivary proteins was 
handled by using individual serum samples instead of serum pools. Additionally, 
enrichment of anti-tick specific antibodies was successful, however, only in very small 
amounts. 
Second, the availability of mRNA as starting material for the construction of antigen 
libraries was limiting. This issue was resolved by pursuing a SMART based cDNA 
synthesis approach which includes an amplification step. 
Finally, the human blood sera and antigen libraries available were successfully screened 
and led to identification of a metalloprotease from I. scapularis that has close homologs in 
other ixodid species as well. Previous reports about the function of this enzyme together 
with vaccination trials of one homolog in I. ricinus impart high potential to this protein with 
respect to acting as a novel vaccine candidate. 
 
4.7 Outlook 
The results presented in this work suggest Metalloprotease 1 from Ixodes scapularis as a 
novel anti-tick vaccine candidate. However, further validation of this protein with respect to 
its potential for triggering immune reactions is needed. The only validation provided so far 
is based on an ELISA using human blood serum and the peptide displaying phage. 
Cloning, expression and purification of the whole protein followed by ELISA analysis with 
different human blood sera is required. For this examination a validated negative control 
serum needs to be identified. 
Furthermore, once the protein has been produced recombinantly, vaccination studies in a 
suitable model organism such as a humanized mouse model can provide deeper insights 
into vaccination potential of MP1. 
Using the bead coupling assay presented in this work, phage display screenings could be 
repeated using the enriched serum antibodies to improve antigen detection. Additionally, 
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with the optimized protocol for library construction, different tick tissues such as the midgut 
as well as different time points of the feeding process could be addressed for antigen 
identification. Finally, the protocols used in this study also can be utilized in analyses of 
other tick species to extend our knowledge of tick-host interactions with particular focus on 
humans. 
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